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Individuals with Parkinson’s disease (PD) suffer from decreased ability to express 
emotion through facial expression, in what has been termed “masked facies” or hypomimia.  
Facial emotional expression is necessary for the accurate communication of needs, to obtain or 
maintain empathy from care-givers, and to be perceived by others in a way that matches the way 
that one feels.  The current study provides a review of the deficits seen in Parkinson’s disease, an 
overview of the neurobehavioral disparity of spontaneous versus posed facial expression of 
emotion, and factors that influence the perception of emotion, such as gender and clinical 
variables.  The relationship between the experience and expression of emotion is also discussed.  
Further, theorized neural mechanisms underlying a current treatment strategy for Parkinson’s 
disease (i.e., The Lee Silverman Voice Treatment – Loud [LSVT – LOUD®; Ramig et al., 2001]) 
is described.  Finally, the neurobiological correlates between vocal production and facial 
expression were examined.  The current study had three aims.  The first one was to explore 
whether LSVT-LOUD® affects spontaneous facial emotional expression in PD compared to 
healthy control groups. Second, we examined whether the internal emotional experience of 
individuals with PD was related to their expression of facial emotion. The third aim was to 
explore whether there were gender differences in how men and women evaluated same- and 
opposite-gendered facial expressions of emotion.   
 
v 
Eighty-two individuals comprised the “the poser participants” (i.e., the participant groups 
of this study), which included PDs receiving the experimental treatment related to voice 
amplitude (LSVT-LOUD®; Ramig et al., 2001), PDs receiving a control therapy involving 
articulation (LSVT-ARTIC®; Ramig et al., 2015), PDs not receiving any therapeutic treatment 
(PD-untrx), and demographically-matched healthy controls (HCs). Using procedures from the 
New York Emotion Battery (Borod, Cicero, et al., 1998; Borod, Welkowitz, & Obler, 1992), all 
participants, while being videotaped, were asked to recall a previously experienced emotional 
event that was happy, sad, or angry, as well as a neutral non-emotional event.  Participants’ self-
reported experience of each emotion was also recorded.  Twenty-four undergraduate-student rater 
participants, naïve to the hypotheses of the study, viewed 15-second silent video clips of posers as 
they recalled the previously experienced emotional or non-emotional events. The “raters” 
evaluated each video on a 7-point Likert scale, from 1 (“very little”) to 7 (“extreme amount”), for 
facial emotional expressivity, in terms of emotional frequency, emotional intensity, and emotional 
variability, as well as social engagement and facial mobility (a non-emotional measure).   
Our results indicated that the PDs in our sample demonstrated impaired facial expressivity 
relative to HCs.  Contrary to our expectation, we did not find an effect of LSVT-LOUD® 
treatment on PDs’ spontaneous facial emotional expressions.  Second, when exploring whether 
PDs and HCs experience monologue emotions similarly, we found no differences between the two 
participant groups.  Finally, when viewing same- and opposite-gender facial expressions of 
emotion, male raters rated all posers as more facially expressive than did female raters.  Female 
raters rated female posers as significantly more facially expressive than did male posers.  The 
results of the current study further characterize the emotional deficits seen in PD and are 
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THE EFFECTS OF A VOICE TREATMENT ON FACIAL EMOTIONAL EXPRESSION IN 




Whether it is the rising of the corners of the lips in a smile or the furrowing of one’s brow 
in disdain, facial expressions are considered the primary way humans communicate emotion. 
Facial expressions act as social cues for the emotional content of an individual’s internal 
experience (Ekman, 1997).  Appropriate displays of facial expression parlay necessary 
information needed for contextually accurate and appropriate social interactions. This applies not 
only to everyday encounters but may play an important role in patient-physician interactions, 
which are imperative for appropriate diagnosis and care. Very few diseases rob an individual of 
the ability to express emotion, specifically, facial expressions of emotion. Parkinson’s disease 
(PD), a disorder most widely characterized by the presence of a resting tremor and general motor 
impairments, is one such disease.  
This review focuses on the facial emotional expressivity disturbances seen in Parkinson’s 
disease. To provide context and support for the proposed research, emotional processing and the 
relationship between gender and the expression and perception of emotion in PD are discussed.  
Posed and spontaneous facial emotional expressions are discussed separately due to their assumed 
neuroanatomical independence and behavioral disparity. Second, this review will also examine 
the relationship between one’s internal experience of emotion and external expression of that 




treatment strategy to improve facial emotional expressivity in PD and the neural mechanisms 
proposed for their effectiveness. Finally, there will be a brief discussion of the neurobiological 
correlates between vocal production and facial expression, which are critical to the research 
proposed.  
Specifically, the aims of this review are: 1) to explore whether the Lee Silverman Voice 
Treatment (LSVT-LOUD®; Ramig et al., 2001) affects spontaneous facial emotional expression 
in PD patients as compared to a treatment control group (i.e., LSVT-Articulation [LSVT-
ARTIC®, Ramig et al., 2015]) and healthy controls (HCs), 2) to examine whether subjective 
internal emotional experience is related to facial expression of emotion, and 3) to explore whether 
there are gender differences in how men and women view same- and opposite-gendered facial 
emotional expressions.  
Emotion and Facial Expressivity 
Emotion has been conceptualized as a “feeling state” which encompasses several 
processes, including cognitive appraisal or perception, goal-directed activity, expressive behavior, 
physiological arousal, and subjective experience or feelings (Plutchik, 1984, 2000).  Physiological 
arousal is when certain types of physiological activation (e.g., hormones, the autonomic nervous 
system, or neurotransmitters) are associated with emotional states (Péron, Dondaine, Le Jeune, 
Gandjean, & Vérin, 2012).  Although the timing and antecedents of such processes are still 
debated among emotion theorists, most would agree that emotion is a process that includes these 
components.  For a discussion of this issue, see Borod (1993). Put simply, emotions are reactions 




The intricacies and variability of emotional states are contingent upon a core set of 
universal basic emotions, which include fear, anger, sadness, disgust, surprise, and expressions of 
enjoyment (Ekman, 1993). In addition to these universal emotions, human beings experience and 
express a number of more complicated social and self-referential emotions, such as 
embarrassment, guilt, pride, and shame (Izard, 1971; Tracy & Robins, 2004, 2007). Both complex 
and basic emotional states are generally accompanied by physiological arousal which most often 
includes either subtle or overt changes in facial expression.  It is well-established that facial 
expression and the recognition of basic emotions displayed via the face are remarkably consistent 
globally and cross-culturally (Ekman & Friesen, 1971; Izard, 1971).  It has been discovered that 
the facial muscles utilized for basic emotions vary little among all humans, whereas the facial 
muscles recruited for all other emotions vary greatly among individuals (Waller, Cray, & 
Burrows, 2008).  This sheds new light on why basic emotions are produced universally and 
recognized a majority of the time.  It is still not known whether more complex “self-conscious” 
emotions (e.g., shame, embarrassment, and pride) may also be universally processed (Tracy & 
Robins, 2004).  
From a psychoevolutionary perspective, humans prosper in a social atmosphere contingent 
upon interpersonal relationships, where accurate displays of emotional expression and successful 
interpretation of such expressions are of great importance.  The basic propensity to recognize and 
correctly interpret emotional expressions engenders greater reproductive fitness (Plutchik, 2000). 
Through various configurations of facial movements, individuals convey both emotional and non-
emotional information to express or even disguise feelings and emotional responses. The natural 
environment creates survival problems for all organisms that must be successfully surmounted.  




potential mates. Because social interactions affect the survival advantage of an individual, and, 
thus, their inclusive fitness, the goals and behaviors of an individual need to be accurately 
perceived, recognized, and understood by others for advantageous social welfare (Parr, Waller, & 
Fugate, 2005; Plutchick, 2000). Further, within these contexts, many individuals are able to parlay 
this knowledge into the more cognitively and developmentally advanced ability of being able to 
project one’s self into the mental state of another, referred to as Theory of Mind (Gallup, 1982). 
Variability in Facial Emotion Processing 
In spite of the universality of facial emotion recognition, proficiency and production of 
facial emotional displays are subject to individual variability, including the reported effects of 
race (e.g., Anthony, Copper, & Mullen,1992; Elfenbien & Ambady, 2002a, 2002b; Matsumoto, 
2002; Zebrowitz, Kikuchi, & Fellous, 2010), gender (e.g., Grunwald et al., 1999; Hall, 1978; Hall 
& Matsumoto, 2004; Zebrowitz et al., 2010), and age (e.g., Borod et al., 2004; Hillier, 
Beversdorf, Raymer, Williamson, & Heilman, 2007).  
In a meta-analysis by Elfenbein and Ambady (2002a), researchers found that there appears 
to be an in-group advantage in perceiving emotional expressions of others, such that emotional 
communication is generally more accurately perceived when the expressor and perceiver share 
membership in the same national, ethnic, or cultural group. Further, in a meta-analysis by 
Anthony et al. (1992), it was found that individuals are more accurate in facial recognition tasks 
of same-race members as compared to other-race members, lending further support to an in-group 
advantage in the perception of facial emotional expressions.  In fact, new research suggests that 
individuals perceive neutral facial expressions of other-race members as portraying more negative 




The processing of emotional stimuli may also be subject to changes across the adult 
lifespan (Grunwald et al., 1999). Research has indicated that older individuals perceive lexical 
emotional stimuli with less accuracy than younger individuals (Grunwald et al., 1999; Hillier et 
al., 2007). It has also been found that older individuals perceive posed-emotional facial 
expressions less accurately than younger individuals (e.g., Borod, Teague, Myers, & Kirch, 2010; 
Malatesta & Izard, 1984; Savage et al., 2013). In contrast, Levenson, Cartensen, Friesen and 
Eckman (1991) did not find significant age-related differences during the perception of emotional 
faces.  
In terms of the production of emotional facial expressions, research indicates that older 
individuals may be less accurate in displaying posed emotional expressions as compared to 
younger individuals (Borod, Yecker, Brickman, Moreno, Sliwinski, et al., 2004; see, also, 
Levenson et al., 1991). In contrast, research examining spontaneous facial expression has not 
indicated changes in the accuracy of facial emotion as a function of age (Levenson et al., 1991; 
Malatesta, Izard, Culver, & Nicholoich, 1987; Malatesta, Jonas, Shepard, & Culver, 1992). Using 
odors to elicit facial expressions of emotion, it was determined that older individuals show 
decreases in spontaneous facial emotion, as compared to younger individuals (Simons, Ellgring, 
& Pasqualini, 2003). These findings are in support of previous research that finds decreases in the 
amount of facial expressivity in older adults (e.g., Diener, Sandvik, & Larsen, 1985; Lawton, 
Kleban, Rajogopal, & Dean, 1992). 
Gender and facial expressions of emotion.  In terms of gender, the literature indicates 
that emotional processing may differ between the sexes (for review, see Borod & Madigan, 2000).  




perceivers of emotional stimuli (e.g., Grunwald et al., 1999; Hall, 1978; Otta, Ambrosia, & 
Hoshino, 1996; Shields, 1991).  In fact, women may also be more emotionally expressive than 
men.  When analyzing posed and spontaneous facial expressions of emotion, Simons et al. (2003) 
found that women were more facially expressive than men, regardless of experimental condition.  
More importantly, evidence suggests that women and men may be differentially effective at 
displaying certain emotions. When presented negatively-valenced images (i.e., gruesome pictures 
of skin disease and severe injuries), Walbott and colleagues found that women exhibited more 
facial activity than did men (Wallbott, Harald, Scherer, & Klaus, 1991). Hess and colleagues 
created avatars (i.e., digitally created human figures) of men and women with comparable facial 
features. They found that the female avatars were perceived as expressing more intense anger and 
that the male avatars were perceived as expressing more intense happiness (Hess, Adams, & 
Kleck, 2004). Research by Kring and Gordon (1998) found that after watching emotional films, 
women were more facially expressive than men for both positive and negative emotions.  Both 
studies suggest a gender by valence interaction for facial emotional displays. 
Facial expressivity among clinical populations.  Within the clinical realm, there is large 
body of literature to suggest that facial emotional expressivity can be compromised in several 
neuropsychological disorders such as schizophrenia (e.g., Blonder, Burns, Bowers, Moore, & 
Heilman, 1991; Borod et al., 1990; Cohen & Minor, 2010; Kring & Moran, 2008; Martin, Borod, 
Alpert, Brozgold, & Welkowitz, 1990), depression (e.g., Borod et al., 1990; Jaegar, Borod, & 
Peselow, 1986), stroke (e.g., Borod, 1992; Borod, Koff, Lorch, Nicholas, & Welkowitz, 1988; 
Kazandjian, Borod, & Brickman, 2007; Montreys & Borod, 1998), Alzheimer’s disease (e.g., 
Henry, Rendell, Sciclun, Jackson, & Phillip, 2009), and Parkinson’s disease (Borod et al., 1990; 




Pentland, 1990; Smith, Smith, & Ellring, 1996). Of particular interest are the emotional 
processing deficits seen in Parkinson’s disease (PD; for review, see McCabe, Borod, Meltzer, 
Speilman, & Ramig, 2010).  Patients with PD demonstrate a decreased ability to express emotion 
through their face and voice.  
Parkinson’s Disease 
Nearly 1 million Americans and 10 million individuals worldwide live with Parkinson’s 
disease (Parkinson’s Disease Foundation, 2016), and it is the second most common 
neurodegenerative disease after Alzheimer’s disease (e.g., Nussbaum & Ellis, 2003). PD is a 
progressive neurodegenerative movement disorder that is associated with the depletion of 
dopaminergic neurons in the substantia nigra pars compacta (e.g., Dauer & Przedborski, 2003). 
This leads to denervation of the nigrostriatal tract and the reduction of dopamine in the striato-
pallidal and pallido-thalamic pathways.  This is what is thought to be responsible for the motor 
deficits seen in PD patients. The telltale signature of PD is Lewy-body pathology (e.g., presence 
of Lewy bodies and Lewy neutrites) seen upon neuroanatomical post-mortem examination (e.g., 
Kalia & Lang, 2015). 
The etiology of PD appears to be a result of both environmental and genetic determinants 
and varying symptomology. There are no diagnostic tests to confirm the presence of the disease 
during the early stages. Quite often, during the early stages of the disease, a diagnosis of PD is 
ascribed based on a patient’s response to the dopamine agonist Levodopa (e.g., Jankovic, 2008).  
The classic motor symptoms of PD include rigidity, resting tremor, postural instability, 




Ramig, 2003).  A diagnosis of idiopathic Parkinson’s disease (IPD) is given when at least two out 
of the four cardinal motor features of PD are present (Ward & Gibb, 1990). Non-motor symptoms 
of PD include constipation, hyposmia (i.e., olfactory dysfunction), excessive daytime sleepiness, 
and rapid eye movement sleep behavior disorder (e.g., Chen et al., 2015), as well as the 
neuropsychological disorders of depression, anxiety, and cognitive impairment (e.g., Aarsland et 
al., 2009; Katsikitis & Pilowsky, 1991).  Another non-motor symptom that can occur is apathy 
(e.g., Pagonabarraga, Kulisevsky, Strafella, & Krack, 2015; Pedersen, Alves, Aarsland, & Larsen, 
2011; Zgaljardic et al., 2007). Of particular note, there is evidence to suggest that non-motor 
(NM) symptomology may occur significantly earlier than the more widely observable motor 
symptoms (e.g., Chen et al., 2015; Dashtipour et al., 2015; Kalia & Lang, 2015; Tolosa, Compata, 
& Gaig, 2007).  Research by Sauerbier, Jenner, Todorova, and Chaudhuri (2015) suggests that at 
least 6 non-motor subtypes of PD exist. These NM PD subtypes are being discovered before the 
observable motor symptoms develop and are characterized by patients presenting with specific 
clusters of the following symptoms: pain, sleep dysfunction, anxiety, cognitive problems, 
anosmia, weight loss or gain, fatigue, gastrointestinal issues, and apathy (Sauerbier et al., 2015). 
These symptoms may also include excessive daytime sleepiness. One theory suggests that these 
symptoms occur due to the Brack hypothesis, which assumes that there is underlying Lewy body 
pathology of the enteric nerves of the olfactory bulb and lower brainstem (Chen et al., 2015). 
Another theory suggests that decreased physical activity is an early symptom of PD, but also a 
catalyst in the degeneration process (Tillerson et al., 2002).  In fact, Fischer et al. (2008) found 
that the PD group that participated in high-intensity work-outs (on a treadmill) showed significant 




weight distribution when going from sit-to-stand (Fischer et al., 2008); these improvements were 
not seen in the low intensity work-out group or in the control group. 
The expression of emotion by individuals with PD has been studied less extensively than 
the perception of emotion in others by those with PD.  Recent research has seen an increased 
focus on the emotional expressivity deficits evidenced in PD.  PD patients have characteristic 
masked or blunted facial expressions that manifest themselves as a reduction in spontaneous blink 
rate, reduced facial mobility, and decreased facial expression. This has been referred to as 
“masked facies” (e.g., McCabe et al., 2010), “hypomimia” (e.g., Mergl, Mavrogiorgou, Hegerl, & 
Juckel, 2005; Priebe et al., 2015), or “mimetic facial paralysis” (Rinn, 1984). These terms refer to 
a general reduction in the speed of facial motor movement with specific decreases in intensity and 
variability of facial movements (e.g., Borod et al., 1990; Bowers et al., 2006; Smith et al., 1996). 
Hypomimia results in a general outward impression of a flat countenance and affect (e.g., Dumer 
et al., 2014). This reduction of facial expressiveness has been shown to be most notably apparent 
during the process of non-verbal facial emotional expression (e.g., Smith et al., 1996).  Patients’ 
reduced ability to express their emotions through facial expressions can lead to negative social 
interactions and impaired social communication. 
Emotional Expression and Parkinson’s Disease  
 Social consequences of disordered facial communication in PD.  The emotional 
expressivity deficits seen in PD lead to various problems in social communication and 
interpersonal relationships (e.g., Brozgold et al., 1998; Dumer et al., 2013; Gunnery et al., 2016; 
Pitcairn et al., 1990; Scott, Caird, & Williams, 1984; Smith et al., 1996). PD patients are also 




likeable (Pentland, Gray, Riddle, & Pitcairn, 1988).  In fact, PD patients notice others’ reactions 
to changes in their communication and, as a result, become embarrassed and withdrawn (Miller, 
Noble, Jones & Burn, 2006). Pentland and colleagues found that during social interactions, PD 
patients are more likely to be assigned negative attributions by others, such as being anxious, 
depressed, unhappy, tense, hostile, and suspicious.  PD patients were also seen as more 
introverted, passive, sensitive, and less intelligent. Further, in a study by Tickle-Degnen and 
Lyons (2004), novice healthcare practitioners incorrectly perceived PD patients as being more 
neurotic and more introverted based on the amount of facial masking they observed.  Specifically, 
patients with decreased facial expressivity were viewed as more neurotic and less extroverted.  It 
is interesting to note that in earlier findings by Pentland et al. (1998), the negative attributes of 
“anxious” and “tense” are closely related to “neuroticism” in the Tickle-Degnen and Lyons study 
(2004). Further, Pentland et al. (1998) also found that PD patients were perceived as more 
introverted compared to healthy controls.  In a more recent study by Tickle-Degnen and her 
colleagues (2011), American and Asian (i.e., Taiwanese) medical professionals viewed videos of 
PD patients and healthy control participants recalling a previously enjoyed event. All practitioners 
were blind to the true purpose of the study. The researchers found that the practitioners of both 
nationalities judged the patients with facial masking as less cognitively competent, depressed, less 
social, and less socially supportive relative to the healthy participants (Tickle-Degnen, Zebrowitz, 
& Ma, 2011).  Further, the health professionals viewed American PD patients with facial masking 
as less sociable than Taiwanese PD patients with comparable deficits in facial expressivity. In 
general, American practitioners were more biased by facial masking, when judging sociability, as 
compared to the Taiwanese practitioners. The study found that Taiwanese practitioners, as 




judging the cognitive competence and social supportiveness of the Taiwanese individuals. Of 
note, the health professionals’ negative attributions towards facial masking were greater for 
female participants than male participants, and even more so for American women (Tickle-
Degnen, Zebrowitz, & Ma, 2011). The findings of this study suggest that the practitioners’ 
negative bias to facial masking reflects one’s own explicit, implicit, gender and cultural norms, 
and stereotypes.  Not only do these findings suggest that Eastern and Western practitioners 
demonstrate a negative bias towards facial masking, their attributions were moderated by the 
effects of the practitioners’ culture and gender of the PD patient.  
Tickle-Degnen and colleagues were not the only investigators to examine the role of 
gender in impression formation involving PD patients with facial masking. When viewing 
videotaped interviews of men and women with PD and subsequent facial masking, individuals 
expressed less interest in potential relationships with women with greater facial masking, and they 
judged the women as less supportive than women without PD. The same results were not true for 
the men who displayed comparable facial masking (Hemmesch, Tickle-Degnen, & Zebrowitz, 
2009).  It is important to note that in this study, the individuals making the judgments were of the 
patient population’s peer group. More specifically, these were older adult observers who also 
made attributional judgments after viewing segments of videotaped interviews of each of the 
members of the study participants. These findings were further supported by a more recent study 
by Hemmesch (2014).  In a similar view, older adults judged PD patients with greater facial 
masking as being more socially negative. Again, the negative bias toward facial masking was 




Investigating the role of valence and facial expressivity in PD, researchers demonstrated 
that positively charged interview questions facilitated, while negatively charged interview 
questions inhibited, facial expressivity in PD patients (Takahashi, Tickle-Degnen, Coster, & 
Latham, 2010). Further, researchers Simons, Ellring, and Pasqualini (2003) found that PD 
participants contract fewer facial muscles when reacting to unpleasant stimuli as compared to 
HCs.  
In a recent study, Gunnery et al. (2016) investigated how hypomimia severity correlated 
with PD patients’ and caregivers’ interpersonal relationships and social lives. Both the PD group 
and the caregiver group answered questionnaires regarding either their own degree of hypomimia 
or the degree of hypomimia for the individual whom they care for. They also answered a variety 
of questions pertaining to their own quality of life.  Both PD-reported and CG-reported 
hypomimia were positively correlated with both partners feeling social rejection. This positive 
correlation diminished when researchers controlled for depression. While still controlling for 
depression, researchers found that the greater the caregiver reported hypomimia, the less 
enjoyment they had interacting with their partner (Gunnery et al., 2016). This study elucidates 
some of the problems that occur in real interpersonal relationships for PD patients and their 
caregivers, who oftentimes are loved ones.   
It is still unclear whether all PD patients suffer from masked facies symptomology, as the 
literature remains equivocal.  Findings have been inconsistent and have varied as a function of 
elicitation condition (Borod et al., 2004). In a review of 23 studies, 57 % of the studies examined 
found significant facial expressivity deficits in individuals with PD (Zgaljardic, Borod, Foldi, & 




al. (2010) reported that 60% of studies investigating emotional processing deficits in PD reported 
facial expressivity deficits.   
However, it is important to better understand the nature of such expressivity deficits in 
order to develop tailored rehabilitative strategies and for comprehensive scientific understanding.  
Before the potential for such interventions are discussed, further delineation of the facial 
emotional expressivity deficits seen in PD patients is presented.  
The relationship between facial emotional expression and experienced emotion.  In 
healthy populations, facial movements provide accurate representations of the subjective 
experience of emotion (Ekman, Friesan, & Ancoli, 1980).  In addition, the extent to which a 
person experiences an emotion can be measured and distinguished through one’s facial 
expressions (Ekman et al., 1980). Furthermore, contracting the same muscles that are utilized in 
making facial expressions during an emotional scenario leads to increased emotional experience 
(e.g., Duclos & Laird, 2001; Laird, 1974; Strack, Martin, & Stepper, 1988; Soussignan, 2002), 
whereas inhibiting facial expressions during an emotional scenario decreases the strength of 
emotional experience (e.g., Davis, Senghas, & Oschner, 2009; Duclos & Laird, 2001). This is 
thought to occur due to the Facial Feedback Hypothesis (FFH). According to the FFH, skeletal 
muscle feedback from facial expressions plays a causal role in regulating emotional experience 
(Buck, 1980).  In the classic study by Strack et al. (1988), half of the participants were directed to 
contract muscles associated with smiling while reading humorous comic strips. Those who 
contracted the muscles that are engaged when smiling reported having an enhanced positive 




There are certain cases where facial expressions of emotion differ from the internalized 
experience of emotion. As stated a bit earlier, women tend to produce more facial emotional 
expressions than men, even though women’s experience and physiological response to emotion is 
equivalent to men (e.g., Kring & Gordon, 1998).  When investigating patients with lateralized 
brain damage, Montreys and Borod (1998) found that right-brain-damaged patients produced less 
intense facial emotion and reported less intense experience of emotion compared to the left-brain-
damaged group. However, there was not a positive correlation between experienced emotion and 
displayed emotion, for each of the brain-damaged groups.  Despite exhibiting some deficits in the 
behavioral expressions of emotion, Alzheimer’s disease patients experience emotion the same as 
their age-matched controls (Henry, Rendell, Scicluna, Jackson, & Jackson, 2009). 
Further research into this area has, for the most part, concluded that among healthy 
participants, facial expressions of emotion and the experience of emotion are correlated (e.g., 
Montreys & Borod, 1998) and that emotional expressions of the face can influence one’s internal 
experience (e.g., Duclos & Laird, 2001; Larsen, Kasimatis, & Frey, 1992).  It is through this 
mechanism that it was first hypothesized that PD individuals might experience a reduction in their 
internal emotional experience due to their reduced ability to demonstrate facial displays of 
emotion. 
Surprisingly, most studies suggest that Parkinson’s disease patients appear to experience 
emotion similarly, and with the same intensity, as healthy controls (e.g., Halfacre et al., 2009; 
Madeley et al., 1995; Smith et al., 1996; Zgaljardic et al., 2003).  In a study by Mikos et al. 
(2009), researchers compared self-ratings of emotional expressivity to ratings made by a family 




participants, despite rating their own facial expressions of emotion as less intense. They also 
found that PD participants accurately appraised their decreased facial expressivity (Mikos et al., 
2009). These findings are in support of research by Borod et al. (2008) where it was found that 
PD patients experience emotion with the same intensity and accuracy as HCs.  In addition, PDs’ 
emotional experience was positively correlated with their observed intensity of facial emotion and 
their frequency of facial emotions. 
Simons and colleagues (2004) quantified spontaneous expressions of amusement and 
correlated them with self-report measures of how amused PD participants felt while watching a 
humorous video. Just as in the Borod et al. (2008) and Mikos et al. (2009) studies, a link between 
emotional experience and expressed emotion in PD was demonstrated. Specifically, the amount of 
spontaneous facial expression demonstrated by the PD group while watching a humorous video 
positively correlated with self-reported measures of how amused the PD participants felt during 
the video.  Despite the PD group’s overall reduction in facial emotional intensity, a link between 
emotional expression and experience was present. Of note, this finding was not present during the 
other conditions of emotional posing, non-emotional posing, or pleasant conversations with a 
spouse or stranger (Simons et al., 2004).  It was speculated that the same result for the 
spontaneous humor condition would not be found during the emotional posing and non-emotional 
posing conditions, as posing or voluntary expressions are not being produced from a genuine 
internal place of feeling or emotion (Simons et al., 2004).  Furthermore, it is possible that for the 
pleasant conversation condition, with either a spouse or a stranger, this condition did not produce 
a strong enough emotion in the PD group.  These findings support other research (e.g., Madeley et 
al., 1995; Smith et al., 1996) where emotional experience in PD seems to be dissociated from 




However, despite convincing evidence, not all research has supported that PD patients 
experience emotion in the same way as HCs. In a review of the literature, Peron et al. (2012) 
suggest that PD patients demonstrate blunted physiological arousal, startle-reflex, and emotional 
appraisal.   
Hypomimia: Volitional (posed) vs. spontaneous facial emotional expression.  
Voluntary (i.e., also termed posed) and spontaneous (i.e., involuntary) facial expressions of 
emotion rely on relatively distinct neuroanatomic pathways (e.g., Borod, Haywood, & Koff, 
1997).  Given that PD is characterized primarily by motoric deficits, it has been proposed that 
voluntary/posed and spontaneous facial emotional expressions would be differentially affected in 
PD patients with masked facies (e.g., Heilman, Blonder, Bowers, & Crucian, 2000).  Spontaneous 
movement is largely controlled by extrapyramidal and subcortical regions, such as the basal 
ganglia (which also controls involuntary movement); whereas, voluntary/posed movements are 
controlled by cortical areas in the frontal lobe (e.g., Blair, 2003; Borod & Koff, 1984).  Therefore, 
it has been postulated that PD patients would have difficulty producing spontaneous facial 
expressions (i.e., subcortical/ basal ganglia) as compared to posed facial expressions (i.e., frontal 
cortex).  In one of the first studies to investigate spontaneous facial expression in PD, Buck and 
Duffy (1980) found that when PD participants viewed emotionally evocative stimuli, raters 
viewed their facial expressions as less expressive than those of the control group.  Second, the 
raters were not able to accurately discern which emotions the PD participants were displaying.  
Using an anatomically based coding system, called FACS (The Facial Action Coding System; 
Ekman & Friesen, 1978), Smith et al. (1996) and Simons et al. (2003) found that, relative to 
controls, PD participants demonstrated decreased intensity in muscle movement, less facial 




the easiest ways you can determine the difference between a Duchenne smile and a non-Duchenne 
smile is that a Duchenne smile will also show certain movements around the eyes. During a 
Duchenne smile, there is wrinkling that occurs at the outer corners of each eye and, sometimes, 
the eyes are slightly squinted.  Within pop culture, on the popular reality television show 
America’s Next Top Model, Tyra Banks referred to these very specific eye movements as 
“smizing,” meaning smiling with your eyes. Since then, “smizing” has become a widely-
recognized word by millions (Graham, 2012). 
McCabe et al. (2010) reported that the total number of smiles between PD individuals and 
HCs do not seem to differ; however, PDs exhibited fewer Duchenne smiles. Halfacre et al. (2009) 
posit that PD individuals are aware of their diminished spontaneous smiling behavior and, 
therefore, compensate by purposely posing a forced (or non-spontaneous smile).  Alternately, 
spontaneous smiling behavior in PD may appear non-Duchenne due to the way the hypomimia 
affects the muscles of the face. It is quite possible that PD-induced hypomimia favors the lower 
portions of the face while causing more pronounced deficits in the upper regions of the face 
(McCabe et al., 2010). Investigating both spontaneous and posed facial expressions in the same 
group of participants, Brozgold, Borod, Rosen, and Alpert (1999) found that PD participants were 
less expressive than controls when engaged in spontaneous displays of facial emotion; however, 
the PD group and control group did not differ in expressivity when engaged in posed facial 
emotions.  These results suggest that spontaneous facial expressions are impaired in PD patients, 
relative to healthy controls.   
In a slightly different study, investigating spontaneous emotional facial expressions in PD, 




individuals. When healthy individuals view emotional facial expressions, although usually 
unaware, they often react with brief automatic facial movements that mimic the face that they are 
viewing. These movements are thought to play a role in social communication and have been 
termed “facial mimicry” (Livingstone et al., 2016). Mimicry is not exactly the same as 
spontaneous movement, as spontaneous mimicry relies on the recruitment and firing of mirror 
neurons in the premotor cortex.  Twenty-seven non-depressed PD individuals and matched 
controls viewed calm, happy, sad, angry, and fearful emotional facial expressions. Overall, the PD 
patients displayed less mimicry compared to the controls. The deficits seemed to vary as a 
function of valence, where mimicked frowns were decreased somewhat but were nowhere near 
the profoundly weakened and delayed mimicry smiles.  
Using odors to elicit spontaneous unpleasant facial emotions, Simons et al. (2003) found 
that the PD patients exhibited less spontaneous facial expressivity relative to healthy controls. The 
PD patients also demonstrated a reduction in facial expressivity under a combined expression 
task. Participants were asked to pose either a negative or positive facial expression while 
simultaneously smelling an unpleasant odor to produce a mixed expression.  In the congruent-
posing condition, the participant would pose a negative expression while simultaneously posing 
an unpleasant odor. In the incongruent-posing condition, the participant would pose a positive 
facial expression while smelling an unpleasant odor.  Having participants smell an unpleasant 
odor either increased their negative facial expression or masked their negative facial expression. 
Interestingly, the congruent-posing condition (i.e., smelling an unpleasant odor while posing a 
negative facial expression) elicited the greatest amount of facial expressivity from the PD 
participants; however, overall, the PD group demonstrated a significant reduction in posed facial 




elicitation procedures of the Simons et al. (2003) study utilized noxious odorants to elicit facial 
expressions of disgust and discontent and a pleasant smell condition was not employed.  
Moreover, other more naturalistic studies have employed the manipulation of mood by either 
having the participant watch a video that induces a feeling state or having the participant recall an 
event that causes them to experience emotion.  The varying methods of emotional elicitation may 
be why there is conflicting evidence in the literature regarding whether spontaneous facial 
emotion in PD is preserved or impaired.  In fact, Bowers et al. (2006b) found that PD patients 
demonstrated blunted reactivity to aversive stimuli and speculated that this muted effect could 
reflect a “bradylimbic” disturbance that is due, in part, to connections between the amygdala and 
the basal ganglia (Bowers, 2006b).  
However, all of the research in this area remains equivocal.  There are studies which have 
not found significant differences in spontaneous facial expressivity between PDs and healthy 
controls (e.g., Madeley, Ellis, & Mindham, 1995; Smith et al., 1996).   
Again, since posed movements are largely controlled by cortical areas (which control 
voluntary movement), it has been postulated that posed facial emotional expressions would be 
relatively spared in PD (Blair, 2003).  Yet, Borod and colleagues (1990) found that PD patients 
were less accurate in displaying posed emotional facial expressions as compared to HCs.  Bowers 
et al. (2006a) argued that posed facial expressions would be influenced by PD in the same way 
intentional movements of the limbs are affected by bradykinesia. Their study concluded that 
relative to healthy controls, PD patients’ posed facial emotional expressions were generated more 
slowly and were of lower expressive amplitude. Yet, Bowers et al. (2006a) conclude that their 




and spontaneous facial expressions in PD, despite conflicting evidence (e.g., Blair, 2003; Borod 
& Koff, 1984; Brozgold et al., 1999).  Jacobs, Shuren, Bowers, and Heilman (1995) demonstrated 
that PD patients posed less intense facial emotional expressions than did healthy controls. More 
specifically, the PD and HC groups differed significantly in producing sad and angry expressions.  
In order to examine the relationship between posed smiling and abnormalities of voluntary 
movement, Marsili et al. (2014) compared the differences in facial expressivity of PD patients 
during a posed-smiling condition and a matched lower-face voluntary-control condition (i.e., 
participants were asked to voluntarily show their teeth as quickly and widely as possible). The 
authors found that facial movements in the PD group were decreased during both the posed-
smiling and voluntary-grinning conditions. The amount of movement for the posed smiles 
correlated with those of the volitional control condition, but only for the PD group. Abnormal 
movement during the posed or volitional condition was related to overall PD motor severity but, 
interestingly, did not improve whether or not patients were on or off L-dopa therapy (Marsili et 
al., 2014).  
In order to clarify the role that elicitation procedure has on facial expressivity, researchers 
analyzed posed and spontaneous facial expressions of PD and HC participants across a number of 
experimental elicitation conditions (Simons, Pasqualini, Reddy, & Wood, 2004).  Participants 
were shown humorous video clips in order to elicit the feeling of amusement.  They then engaged 
in conversation on a positive/pleasant topic and were then asked to pose a happy, sad, angry, 
fearful, sad, surprised, or disgusted facial expression or to imitate a non-emotional facial 
movement. Researchers found that the PD participants demonstrated a reduction in spontaneous 




et al., 2004).  Furthermore, the PD participants were less expressive than the controls when posing 
emotional expressions and imitating non-emotional facial movements.  
In one of the most recent studies published on facial expressivity in PD, Priebe et al. 
(2015) examined facial expressions of pain in PD.  Similar to the findings of Simons et al. (2004), 
facial displays of pain were decreased compared to controls. Interestingly, there were noticeable 
qualitative facial expressivity differences between the PD and HC groups during the experience of 
pain. In the HC group, narrowing of the eyes was the most frequent movement while experiencing 
pain; yet, this movement was demonstrated least frequently by the PD group, out of all of the 
pain-related movements. Further, the most frequently displayed movement for the PD group, 
while experiencing pain, was opening the mouth, which is not considered to be a pain-related 
movement.  Priebe et al. (2015) found that the movements of the upper face (i.e., the narrowing of 
the eyes) was affected the most while the movements of the lower face, although atypical, were 
relatively preserved (Priebe et al., 2015). These findings, coupled with the findings mentioned 
earlier on non-Duchenne smiling in PD (McCabe et al., 2010), suggest that hypomimia may 
differentially affect the upper and lower face.  
Rehabilitation of Hypomimia in Parkinson’s Disease 
A variety of behavioral and neurological studies have looked at the expressive deficits in 
PD; however, very few have attempted to provide a treatment for hypomimia in PD (Dumer et al., 
2014; Elefant, Lotan, Baker, & Skeie, 2012; Katsikitis & Pilowsky, 1996; Ricciardi et al., 2016; 
Spielman et al., 2003). The Katsikitis and Pilowsky (1996) treatment study investigated the 
effects of orofacial physiotherapy, specifically, by brushing the facial muscles of participants. 




possible effects; PD participants could open their mouths wider, after treatment. This result could 
have simply been due to client/clinician interaction. In Elefant et al. (2012), they discovered that 
music therapy improved hypomimia in PD patients; however, the lack of a control group for 
comparison weakened the study’s methodology and veracity of their findings. A study by 
Ricciardi et al. (2016) involved a multi-modal approach in rehabilitating hypomimia. However 
promising, their study suffered from small sample sizes, thus preventing firm conclusions 
regarding the study’s results. In 2003, Spielman and colleagues first reported the preliminary data 
and results they obtained from treating 22 PD patients with LSVT versus a matched control group 
of 22 PD patients treated with a respiratory therapy (Spielman et al., 2003). The PD patients who 
received LSVT were rated as having greater facial mobility and higher levels of social 
engagement than the control group. These results were encouraging, and further studies have 
investigated the role of LSVT’s effectiveness in treating hypomimia.  
Vocal Deficits in Parkinson’s Disease 
The emotional deficits seen in PD are not limited to just the face, but are evidenced in the 
voice, as well.  Nearly 90 percent of the 1.5 million patients with PD exhibit speech and voice 
symptoms, and at least 75% of patients with PD are classified as having a speech disorder; yet, 
only 3-4% of patients receive speech therapy (Logemann, Fisher, Boshes, & Blonsky, 1978; 
Ramig, Countryman, O’Brien, Hoehn, & Thompson, 1996; Ramig, Countryman, Thompson, & 
Hori, 1995).  Hoarse voice quality, soft voice (i.e., hypophonia), monotone voice, breathy 
phonation, reduced and imprecise articulation, reduced prosody (i.e., hypoprosodia), and vocal 
tremors contribute to the dysarthria and communication issues seen in a large number of PD 




abnormalities, such as longer pauses during speech, decreased vocal sound pressure (SPL), 
shorter duration of sustained phonation, and an overall reduction in speech intelligibility has also 
been demonstrated (e.g., Ramig et al., 2004; Sapir, Ramig, & Fox, 2011; Sapir et al., 2007).  
Unlike their facial expressivity deficits, PD patients are usually unaware of their own 
hypophonic deficits.  Interestingly, when they are prompted to speak with increased volume, PD 
patients often report feeling as if they are speaking too loud (Liotti et al., 2003).  Similar to the 
facial expressivity deficits seen in PD, their disordered speech limits their ability to function 
normally in society (Ramig et al., 1996). 
The Lee Silverman Voice Treatment – LOUD (LSVT- LOUD®) 
The Lee Silverman Voice Treatment (LSVT - LOUD®; Ramig et al., 2001) is an intensive 
speech treatment that trains PDs with hypophonia to speak with greater amplitude while self-
monitoring the effort it takes to produce such vocalization (Ramig et al., 1996).  LSVT-LOUD 
has been shown to be particularly effective in increasing vocal intensity/amplitude in PD 
individuals demonstrating hypophonia.  The LSVT- LOUD treatment is designed to target 
inadequate muscle activation underlying hypokinesia (i.e., reduced amplitude of movement) and 
bradykinesia (i.e., slowness of movement) in PD (Fox et al., 2006).  The program focuses on 
maximizing phonatory and respiratory functions by instructing patients to produce sustained loud 
phonations, using maximum effort (Sapir et al., 2011), in a variety of speech tasks (Ramig et al., 
2001).  It is hypothesized that intensive highly effortful voice therapy teaches the patient to 
rescale the magnitude of speech-motor output (Ramig et al., 1996). The LSVT capitalizes on the 
known effect for high effort (i.e., demonstrated through either complexity or difficulty) tasks, 




(Farley, Fox, Ramig, & McFarland, 2008). This effect has been successfully demonstrated in 
animal models of PD and transcranial magnetic stimulation (TMS) studies in humans (for a 
review, see Farley et al., 2008).  The LSVT- LOUD treatment encourages increased vocal 
amplitude on the respiratory and articulatory systems of speech (e.g., Sapir et al., 2007).  It is 
important for patients to have knowledge of how they are doing and to use that information going 
forward in treatment (Ramig et al., 1996). Feedback is given directly to the patient since he/she 
must rely on internal cueing to maintain the desired vocal amplitude changes over time (as 
opposed to relying on external cues). As a result, the training requires learning, memory, 
motivation, and self-reliance (Sapir et al., 2007). The entire treatment consists of sixteen 60-
minute sessions, for a total treatment protocol of one month.  
Voice abnormalities in PD patients have been attributed to asymmetric vocal fold tension 
or movements, stiffness or rigidity of the vocal folds and respiratory muscles, glottal 
incompetence, reduced laryngeal muscle activation or synergy, dysfunctional vocal fold 
adduction, and muscle atrophy or fatigue (Ramig et al., 2001; Sapir et al., 2007). Given that there 
is pathology observed in laryngeal and respiratory function in PD patients (Ramig et al., 1996) 
and that orofacial and extrinsic laryngeal muscles ultimately regulate the vocal tract and vocal 
amplitude (Sapir et al., 2007), vocal loudness serves as a trigger for distributed effects across the 
speech production system (Fox et al., 2006). The loud and phonatory tasks of LSVT- LOUD have 
been designed to improve vocal fold adduction, vocal tract configuration, respiratory drive, 
supralaryngeal articulatory movements, and laryngeal muscle activity and synergy (Ramig et al., 
2001). Such exercises have been shown to improve voice quality, resonance, prosody, amplitude, 
articulation, and speech intelligibility. The increased vocal fold adduction allows patients to 




interaction between aerodynamic and vocal fold visoelastic forces (Sapir et al., 2007).  
Individuals with PD integrate improved speech into functional communication (Fox et al., 2006). 
However, the role of self-monitoring is a key aspect of the treatment which is critical. 
In Narayana et al. (2009), PD patients displayed abnormalities in several speech regions, 
yet through the use of the LSVT-LOUD treatment, functional imaging showed that changes to 
these regions occurred. Using H20-Positron Emission Tomography (PET), Narayana and 
colleagues (2009) found a post-treatment related shift in neuronal activity toward the right 
hemisphere.  Further, they found greater correlated activity within the right dorsolateral prefrontal 
(DLPFC), temporal (i.e., auditory), and speech-motor regions.  Specifically, 1) the DLPFC is not 
an area activated during speech tasks in healthy individuals, 2) as speech became more normal in 
the PD group, regional cerebral blood flow (rCBF) in the DLPFC increased, and 3) rCBF is 
absent at the level of the basal ganglia. Taken together, these results suggest that the LSVT- 
LOUD intervention caused its effect via a top-down mechanism (Narayana et al., 2009). The 
LSVT-LOUD treatment, through a neuroplastic rehabilitative mechanism, increased recruitment 
of the right auditory cortex and improved communication among right-hemisphere (RH) speech-
motor regions (Narayana et al., 2009).  Such improvements to the sensory-motor speech system 
are thought to cause an auditory recalibration in which increased self-awareness of loudness is 
normalized (Narayana et al., 2009). The shift in activation to the RH demonstrates increased 
recruitment among the regions of the brain devoted to global aspects of prosodic speech, such as 
loudness, pitch, and tone (Narayana et al., 2009). 
As of 2009, only 2 studies had investigated the differences between the speech motor 




speech tasks, PD patients in both studies had significantly greater rCBF in prefrontal and 
premotor cortices during speech tasks, as compared to matched healthy controls. In response to 
the decrease in blood flow for the areas involved in the planning of motor movements (i.e., 
premotor and prefrontal), both studies reported altered rCBF in the motor areas of the primary 
motor cortex and cerebellum, finding both increases (Liotti et al., 2003) and decreases (Pinto et 
al., 2004).  
LSVT-treated patients improved or maintained vocal intensity at or above pre-treatment 
levels one year post-treatment. The respiratory control group’s vocal intensity deteriorated 
significantly at 12 months (Ramig et al., 1996).  What has been the most interesting and 
surprising finding has not only been how LSVT has improved vocal intensity in PD patients but 
how it has contributed to increases in facial expressivity (Spielman, Borod, & Ramig, 2003).  
Initially, LSVT-LOUD was developed to treat voice and speech deficits in PD; the benefit of 
increasing facial expressivity (as demonstrated in Spielman et al., 2003) was, at first, an 
unexpected serendipitous finding. 
The Lee Silverman Voice Treatment – Articulation (LSVT-ARTIC®) 
The LSVT Articulation Therapy (LSVT – ARTIC®; Ramig et al., 2015) is another voice 
treatment developed by Ramig and colleagues (Spielman et al., 2012) intended to help improve 
articulation in PD patients.  Due to several factors, including the same intensive schedule of 
treatment as the LSVT-LOUD program, LSVT-ARTIC is also similar to LSVT-LOUD in the 
amount and type of feedback given to a patient, as well as the amount of patient and therapist 
interaction. However, instead of focusing the treatment on increasing vocal amplitude, as in 




treatment involves over-articulating vowel, consonant, and vowel consonant sounds. Due to their 
similar schedules of treatment and focus on the voice, it was hypothesized that LSVT-ARTIC 
might also have a positive effect on facial expressivity. However, recent studies have shown that 
such improvements are not seen after LSVT-ARTIC therapy.  When considered from a 
neuroevolutionary perspective, post-treatment increases in facial expressivity accompanying 
improved vocal loudness suggests that a treatment aimed at increasing vocal amplitude may be 
stimulating phylogenetically-old neural centers of the brain, such as thalamic, limbic, and 
reticular connections (Spielman, 2000). Whether it’s a mating call or a warning that danger is 
approaching, phonation plays a large role in the vocalization of birds and primates (Petkov & 
Jarvis, 2012). Birds and primates have the same phylogenetically-old areas of the brain as we 
have (Petkov & Jarvis, 2012).  However, articulation, an aspect of voice production specific to 
human beings, is controlled by the neocortex (Spielman, 2000), a phylogenetically-newer neural 
area. Since LSVT-ARTIC is acting at the cortical level, it is expected that it would not have the 
same effect on the subcortical emotional centers of the brain, thus, not impacting facial 
expressions of emotion.   
Since LSVT-LOUD and LSVT-ARTIC share similarities such as high-effort, intensive 
treatment, clinician feedback, clinician-patient interaction, and a high focus on the same channel 
of communication (i.e., the voice), LSVT-ARTIC is the perfect treatment control group for the 
LSVT-LOUD group (Spielman, 2000). As such, the LSVT-ARTIC therapy will be used as a 
treatment control in the proposed study.  




The finding that a voice therapy could improve facial expressivity is supported by 
numerous theories linking vocal and facial expression (for review, see Bono & Borod, 2016).  In 
one such study by McClean and Tasko (2002), correlations were found between lip, tongue, and 
jaw movement speed and breathing volume. These results suggest that there is an underlying 
neural substrate coordinating mouth movements for speech and breathing rate for vocalization.  It 
has been suggested that the voice and face are linked components of a complex coordinated 
system designed to express one’s internal state (Kaiser & Scherer, 1998).  According to Damasio 
(1995), there is an underlying common neural network between regions that mediate our 
emotional responses; these include the basal ganglia and the anterior cingulate cortex.  In 
addition, there is a common facial musculature which expresses the functions of both language 
and facial expressions (Rinn, 1984).  Both the larynx and face are innervated by the same lower 
motor neuron tract (i.e., the seventh cranial nerve or facial nerve; Rinn, 1984).  Given these 
commonalities, it is not improbable to suggest that improvements in one system (e.g., the voice) 
may facilitate improvements in the other (e.g., the face).  
If we are to understand the connectivity between the voice and face, we must first 
understand their shared neural mechanisms. The brain innervates the muscles of the face via the 
corticospinal tract (Blumenfeld, 2010).  The corticospinal tract is composed of upper and lower 
motor neurons.  Upper motor neurons carry electrical impulses from the primary motor area of the 
frontal lobe to the lower motor neurons located in the brain stem or spinal cord. These lower 
motor neurons consist of cranial nerves V and VII, which then carry the impulses to the face 
(Blumenfeld, 2010). Cranial nerve V (i.e., the trigeminal nerve) controls chewing and facial, 
mouth, and tongue sensations, while cranial nerve VII (i.e., the facial nerve) controls facial 




cranial nerve VII) has five main branches that are responsible for different functions; further, 
different branches of this cranial nerve innervate the lower, middle, and upper portions of the face 
(Blumenfeld, 2010; Rinn, 1984). 
Although the function and anatomy of the trigeminal and facial nerves are distinct and 
independent of one another, there is growing evidence to suggest connectivity between them (e.g., 
Felizardo et al., 2010; Tanaka, Yu, & Kitai, 1971).  In an electrophysiological study, Felizardo et 
al. (2010) were able to demonstrate that the trigeminal nerve (responsible for somatosensation of 
the tongue) modulates the neurons arising from the facial nerve (responsible for taste) at the level 
of the Nucleus of the Solitary Tract (i.e., medulla and lower pons).  The connectivity between the 
5th and 7th cranial nerves may be a partial mechanism to explain the relationship between the face 
and voice. 
However, some of the most convincing evidence comes from studies that have 
investigated the cortical and subcortical substrates involved in regulating vocal and facial 
expressions of emotion (e.g., Hopf et al., 1992; Jürgens & Zwirner, 1996; Özeren, Sarica, & Efe, 
1994; Ross & Mathiesen, 1998). The anterior cingulate cortex (ACC) projects to the peri-
aqueductal grey (PAG), an area that is thought to integrate motor systems for vocalizations 
(Blumenfeld, 2010). The medial dorsal nucleus of the thalamus (MDN) projects to the larynx 
directly and also via the PAG (Devinsky et al., 1995; Rinn, 1984). The MDN, as well as many 
other thalamic nuclei, communicate to and from the ACC, which is believed to be involved in 
automatic emotional vocalizations, as well as deliberate vocalizations, through its connection to 
motor neurons in the larynx (Devinsky et al., 1995; Ploog, 1987).  It is through these thalamo-




from the basal ganglia) projects to the MDN which then projects to the ACC, in preparation for 
vocalization (Devinsky, 1995). This theory suggests that the thalamus is the main link between 
facial expressions of emotion and vocal production. In fact, a number of studies using electrical 
stimulation (e.g., Jürgens & Zwirner, 1996) or thalamic lesions (e.g., Hopf et al., 1992; Özeren, 
Sarica, & Efe, 1994; Ross & Mathiesen, 1998) lend support to this theory.  In fact, lesions of the 
striatum have been known to cause emotional facial paresis, where spontaneous smiling or 
weeping can occur, but volitional movements of the face are preserved (Trosh, Sze, Brass, & 
Waxman, 1990). However, Davis, Zhang, Winkworth, and Bandler (1996) hypothesize that the 
PAG is the crucial brain site for mammalian voice production, not only for emotional vocalization 
or involuntary sounds, but for larynx control and respiration that are essential for human speech. 
Moreover, it has been discovered that mammals’ facial motor nucleus, which controls facial 
expressions, has widespread projections to respiratory-related areas of the brainstem (Li, Guan, 
Chan, & Zheng, 2004). 
Jürgens and Zwirner (1996) discovered two vocal control pathways, one neocortical 
pathway and one limbic pathway, using electrical stimulation.  Vocalizations by electrically 
stimulating the ACC and the hypothalamus ceased when a blocking agent was injected into the 
peri-aqueductal grey (PAG); however, this injection had no effect on vocal fold movements 
elicited by electrically stimulating the motor cortex of the squirrel monkey (Jürgens & Zwirner, 
1996).  These findings can be further supported by the findings of Brown, Ngan, and Liotii 
(2008); when using fMRI, researchers were able to map the movements of the larynx onto the 
motor strip of human primary motor cortex just slightly superior to where the lips are represented 




cerebellum can severely impair a person’s facial emotional expressivity and prosodic ability 
(Heilman, Leon, Burtis, Ashizawa, & Subramony, 2014). 
 Further evidence comes from studies investigating the relationship between facial and 
vocal expressivity. Borod, Koff, Lorch, and Nichols (1985) found significant correlations between 
facial expressivity and vocal intonation for both brain-damaged and healthy control groups. 
Another study evaluating correlations between vocal and facial expression of emotion with 
patient groups with PD, right-sided brain damage, depression, and schizophrenia, as well as 
healthy controls reported similar findings (Borod et al., 1990).  Borod et al. (2000) was able to 
demonstrate support for a general processor for emotional perception tasks, across modalities 
(i.e., face, voice, and speech content) in 100 healthy men and women. Taken together, these 
studies support the idea of a central mechanism regulating emotional expression across various 
channels of communication. 
Hypomimia limits PD patients’ ability to express themselves accurately. This leads to 
misattributions by others, PD patients feeling embarrassed to communicate (Miller, Noble, Jones, 
& Burn, 2006), loss of interest from caregivers (Gunnery et al., 2016), and overall decline in 
quality of life for the individuals affected.  Therefore, it is imperative that we understand the 
nature of such expressivity deficits in order to develop tailored rehabilitative strategies and to 
further our scientific understanding of emotion. 
To date, LSVT-LOUD has provided patients with a state-of-the-art (Trail et al., 2005) 
multi-dimensional treatment option to treat hypomimia in PD. LSVT-LOUD is based on 
principles derived from motor learning, muscle training, neurology, physiology, and 




parameter of vocal loudness can result in widespread and distributed effects, as seen in 
improvements in facial emotional expressivity. It is hypothesized that through neuroplasticity, a 
variety of motor behaviors, including those from seemingly different motor systems, such as 
speech and spontaneous facial expression, can show improvement (Fox et al., 2006). After LSVT- 
LOUD treatments, functional imaging revealed cortical activations more closely resembling 
activations seen in HCs; this included the additional recruitment of right anterior insular cortex, 
caudate, putamen, and the DLPFC (Liotti et al., 2003). 
The purpose of the present study is to examine the effects of LSVT-LOUD on measures of 
facial expressivity in individuals with idiopathic Parkinson’s disease.  In order to discern that 
LSVT-LOUD is responsible for the changes in facial expressivity post-treatment, participants will 
be randomly divided into a treatment group (LSVT-LOUD), an articulation control treatment 
group (LSVT-ARTIC), an untreated PD control group (PD-untrx), and a matched healthy control 
group (HC). 
Aims 
Aim 1a. To examine whether the Lee Silverman Voice Treatment (LSVT-LOUD®; 
Ramig et al., 2001) affects facial emotional expression in Parkinson’s disease patients during the 
recollection of past emotional experiences compared to demographically-matched healthy 
controls (HCs). Preliminary research (Spielman et al., 2003) showed that PD patients treated with 
LSVT- LOUD, compared to a control respiratory therapy, displayed a significant increase in 
facial mobility and social engagement after treatment. However, this preliminary study included a 
small sample and was limited in scope. The current study seeks to replicate these findings using a 




emotional frequency, emotional intensity, and emotional variability), as well as social 
engagement and facial mobility (i.e., a non-emotional control measure). Examining the effects of 
LSVT-LOUD on these measures may provide insight into whether facial emotional expressivity 
is mediated by a motoric, potentially neuroanatomical, mechanism or whether emotional 
regulation is being more directly affected. We hypothesize that PD patients will show greater 
increases in measures of facial emotion, from baseline to post-LVST-LOUD treatment relative to 
post-LSVT-Articulation (LSVT-ARTIC®; Ramig et al., 2015) and healthy controls.  Based on 
previous findings (Spielman et al., 2003), we also predict that PD patients will demonstrate 
increases in Social Engagement post-LVST-LOUD treatment relative to the LSVT-ARTIC group 
and healthy controls. 
Aim 1b.  In an attempt to better characterize the facial emotional expressivity deficits seen 
in PD, we utilized a recently developed (Borod et al., 2007) and more refined systematic rating 
system where we divided the overall construct of Emotional Expressivity into three distinct 
components: 1) Emotional Frequency (EF), 2) Emotional Variability (EV), and 3) Emotional 
Intensity (EI). We anticipate that these measures will provide us with a more comprehensive way 
to delineate the nature of the facial emotional expressivity deficits seen in PD and in other clinical 
disorders. Moreover, we wanted to explore a unique aspect of the psychosocial impairment seen 
in dyadic interactions between PD patients and the perceiver by including the variable “Social 
Engagement (SE).” By including a measure of social engagement, we assumed a more 
ecologically valid approach that might better characterize the everyday psychosocial and 




Aim 2. To examine whether subjective emotional experience (i.e., how intensely 
participants feel the emotion) during the recollection of past emotional events is related to the 
three measures of facial emotional expressivity.   Based on the literature (e.g., Borod & Montreys, 
1998), we hypothesize that there will be a moderate correlation between HCs’ self-reported 
experiences of emotion and observed ratings of their facial expressions of emotion. For the PDs in 
both treatment groups, a less strong, or a negligible, relationship between these variables is 
anticipated.  
Aim 3. To examine whether there are gender differences in how men and women view 
facial emotional expressions of the same and opposite gender.  The majority of studies in the 
literature have shown that women are more accurate perceivers of emotion than are men (for 
reviews, see Borod & Madigan, 2000; Grunwald et al., 1999). As such, we hypothesize that male 
and female raters may differ in how they perceive the facial emotional expressions of the male 
and female participants in our experimental and control groups. Further, these differences may 
vary depending on the gender of the facial stimuli viewed, lending further support to the existing 




Two sets of study participants will be utilized in this study: Posers and Raters.   
Poser participants. The poser participants consisted of 64 individuals with idiopathic 




20 demographically-matched healthy adult controls ranging in age from 46 – 80 years old (M = 
64.6 years, SD = 9.2).  Poser participants’ demographic and clinical information is summarized in 
Table 1. 
All poser participants, or “posers,” were recruited from the Boulder and Denver, Colorado 
area through physician referrals, support groups, and aging centers. Approved advertisements 
were posted in newspapers, on email listservs, in newsletters, on websites, and in research and 
educational facilities. Prior permission was obtained from each recruitment site via IRB approval.  
Each poser was paid $10 for the initial screening phase and $30 for experimental participation. 
All posers were treated in accordance with the guidelines and standards set forth by the Colorado 
Multiple Institutional Review Board (COMIRB) at the University of Colorado, as well as the IRB 
at Queens College of the City University of New York.  
Posers were given a series of medical, cognitive, and physiological tests to ensure that 
they met the overall inclusionary criteria.  Exclusionary criteria included the following: severe 
depression (cut-off score > 28; measured by the Beck Depression Inventory-II; Beck, Steer, & 
Brown, 1996); mild, moderate, or severe dementia (cut-off score < 24; measured by the Mini-
Mental Status Examination; Folstein, Folstein, & McHugh, 1975); symptoms of a neurological 
condition other than PD; substance abuse; head or neck cancer; significant history of 
gastrointestinal disease or surgery (as defined by an otolaryngologist); speech-language disorders 
unrelated to PD (as defined by a speech-language pathologist); neurological surgical treatment if 
it was not a surgical treatment specifically for Parkinson’s symptoms; laryngeal surgical 
treatment, laryngeal pathology (as defined by an otolaryngologist); participation in any intensive 




temporomandibular joint (TMJ) disorder; or pregnancy. No participant had hearing loss 
unexpected for his/her chronological age (based upon audiological screening). Patients did not 
change medications or dosages during the speech treatment period and were 
neuropharmacologically stable during speech treatment period.  Inclusion criteria included the 
following: 45-85 years; PD Stage I-IV (Hoehn & Yahr, 1967); none or mild dementia; none, mild, 
or moderate depression; and mild, moderate, or severe speech and voice disorder. Written 
informed consent was obtained from each poser participant through the Colorado IRB. 
Rater participants.  Four groups of six Caucasian rater participants (12 male and 12 
female) were recruited via IRB-approved flyers at Queens College in Flushing, NY.  All 24 rater 
participants, or “raters,” were Queens College students who ranged in age from 18-39 years old.  
They were recruited as study participants and were screened for inclusion/exclusion criteria (see 
Appendix A) using one of the screening instruments from the New York Emotion Battery 
(NYEB; Borod, Welkowitz, & Obler, 1992). One of the inclusionary criteria is that all raters be 
Caucasian. This was necessary due to the fact that the posers in the larger study were almost 
exclusively Caucasian due to the geographical area in which the experimental data were 
collected.  As stated, recent literature has demonstrated an effect of ethnicity on the perception of 
emotional expression (i.e., the “in-group advantage;” Anthony et al., 1992; Elfenbein & Ambady, 
2002a). Further inclusionary criteria for the rater participants included: being right-handed, being 
native-speakers of English, and having no history of neurological disorder, head injury, learning 
disability, psychiatric disorder, or substance abuse.  Raters were compensated at the rate of $9 per 
hour for participation in this study. All rater participants were treated in accordance with the 
guidelines and standards set forth by the Queens College IRB, and written informed consent was 




Materials and Procedures 
Poser procedures.  
LSVT-LOUD® and LSVT-ARTIC® treatment protocols.  All poser participants took part 
in the research protocol in the lab of Dr. Lorraine Ramig at the University of Colorado-Boulder.  
Poser participants with PD were randomly assigned to one of the following three groups: 1) 
LSVT– LOUD, 2) LSVT- ARTIC, or 3) PD untreated. The HC participants were 
demographically matched. 
Those assigned to the LSVT-LOUD® (Ramig et al., 2001) group were required to attend 
sixteen 50-60‒minute private treatment sessions in a month. Within each week, participants had to 
attend four consecutive days of treatment.  During LSVT-LOUD treatment sessions, poser 
participants were instructed to sustain the vowel “ah” loudly for as long as they can, for a 
maximum of 12-15 times. Then the poser participants were instructed to sustain the vowel “ah” 
for 5 seconds in the highest and lowest pitch that they can produce, for a maximum of 12-15 
times, for each pitch.  The loudness was trained by the clinician and appropriate feedback was 
given.  In each session, poser participants used their newly trained “loudness” in speaking 10 
phrases repeated 5 times each.  This part of the treatment took approximately 30 minutes. For the 
remaining 30 minutes, the clinician worked the patient through a Speech Hierarchy that started 
with phrases and progressed gradually to conversation.  The clinician began with phrases and 
sequenced to sentences, then reading, and finally conversation.  This was completed all while the 
participants were speaking loudly. Participants were cued to “be loud” for each task.  Homework 
was assigned to help carryover the skills learned in treatment to everyday life.  




LSVT-LOUD program. The same treatment schedule (i.e., duration and number of visits) was 
used for the LSVT-ARTIC therapy as was for the LSVT-LOUD therapy.  Poser participants were 
instructed to over-articulate and repeat a single phoneme such as “ta”, “pa”, or “ka.”  The Iowa 
Performance Instrument (IOPI) was used periodically during this task to measure tongue strength 
and endurance. The IOPI device has a soft rubber bulb that is placed in the front of the mouth of 
the participant, while the poser participant says each phoneme.  In accordance with the 
manufacturer’s instructions (i.e., Northwest Company, LLC), each bulb was disinfected in 
Cavicide before the first use and washed with soap and water between uses.  Each participant was 
provided with their own new bulb; bulbs were not shared among participants.  This first task of 
phoneme repetition continued for 10 minutes. During the next 10 minutes of treatment, the poser 
participants repeated and over-articulated, with high effort, contrasting phonemes such as t/k. The 
clinician used the word “enunciate” to cue the participant.  All homework, carryover tasks, and 
sensory training was equivalent for both treatment groups and was taught during the treatment 
session.  Much care and attention was placed in treating the LSVT-LOUD and the LSVT-ARTIC 
patients in a similar manner and in providing the same amount of positive reinforcement to each 
group.  
Facial expression protocol.   Posers were seated comfortably in a dental examining chair 
with a headrest in a sound-resistant booth (Industrial Acoustics Company [IAC]).  All individuals 
were video-taped using a Canon XL1S mini DV video-camera.  The camera was positioned 
approximately 9 feet away from the participant, centered, and zoomed-in to capture the face and 
head of each poser from the neck up.  The experimenter was seated next to the video-camera in 
order to provide instructions and prompting, if necessary.  Posers were asked to produce 




Borod, 1998).  All posers were asked to recollect experiences pertaining to 3 different emotions 
(i.e., anger, sadness, and happiness), separately, with the order of monologue type 
counterbalanced among all poser participants. The neutral monologue was always produced first 
in order to control for any potential emotional carry-over effects that could contaminate non-
emotional expression. 
Each poser was given the following instructions: “We are interested in studying the kinds 
of emotional events that are important to people. I would like you to talk about emotional 
experiences involving each of three different emotions, which I will present to you one at a time, 
such as fear. Try to remember and actually relive a time that you felt the emotion that I ask you to 
talk about. I would like you to recall the time that you felt this emotion with the greatest intensity. 
Put yourself back into the situation and try to re-experience it with as much real feeling and 
intensity as when it actually occurred.  Describe what happened and how you felt in detail.  I am 
going to leave the room for a moment, let me know when you are ready, and I will come back in 
the room.  When I return, begin to speak as soon as you feel you can vividly remember and feel 
the experience.  Please speak for at least 90 seconds. Here is an example of how you might 
describe an event involving the emotion of fear.”  Posers were then provided with a sample 
emotional monologue.  If the participant was having difficulty, the examiner provided 
standardized probes (Borod et al., 1992; Montreys & Borod, 1998).  This procedure was repeated 
for happy, angry, and sad emotional experiences.  For control purposes, each poser was also asked 
to talk about a neutral, non-emotional experience (i.e., watching television).  For the neutral 
monologue, the poser participants were given the following instructions: “We are interested in 
studying everyday activities, in other words, things that you do regularly.  I would like you to talk 




to remember and reconstruct the last time that something happened related to the topic that I ask 
you to talk about. Put yourself back into the situation and try to reconstruct it with as much 
accuracy and precision as when it actually occurred.  Describe the event in detail. Please begin to 
speak as soon as you can remember what happened.  Try to speak for at least 90 seconds.  Please 
make sure that the situation you describe is not an emotional one. Here is an example of how you 
might describe an event involving watching TV.” The posers were then provided with a sample 
narrative to help them. Again, standard probes were used by the examiner, if needed. 
After completing each emotion monologue, participants were asked to report their 
subjective experience of emotion during the monologue on a 7-point Likert scale, from “1” 
(minimal) to “7” (maximal).  The experiential ratings were not collected for the neutral 
monologues.  Using procedures developed by Borod et al. (2008), participants were first 
instructed to report the intensity of their feelings immediately following the monologue with the 
prompt “On a scale of 1-7, please indicate how happy, sad, or angry you feel right now” (i.e., 
immediate experience). Next, accuracy was assessed with the prompt: “How accurately were you 
able to express the specific emotion that you experienced during the situation which you just 
described” (i.e., accuracy of experience). Finally, intensity of their emotional experience, during 
the monologue, was assessed via the prompt: “Please indicate how intensely you relived the 
experience and felt the emotion that you were talking about just now” (i.e., intensity of feelings). 
 These data were recorded at the University of Colorado, Boulder and were then sent on 
DVD to Dr. Joan C. Borod’s Emotion Lab, at Queens College, for processing and analysis. 
 Rater procedures.  The experimental data (i.e., the poser monologues) were split into 




for each of the four monologue types.  This resulted in a total of approximately 6,000 video 
segments across the 84 posers.  Using an in-house video-stimulus presentation software 
(programmed in Microsoft Access v. 2007), 24 raters (12 female and 12 male) were presented 
with the experimental poser data on a 17-inch flat panel LCD computer monitor.  Each poser-
video segment was 3.75” x 3.5”.  In order to control for order effects (i.e., poser group, emotion 
type, and poser gender), all segments were completely randomized and presented to the raters 
individually. Segments were viewed without audio so that the raters were not aware of which 
emotion they were viewing.  Further, the raters were naïve to the study’s hypotheses and subject-
group characteristics.  The raters were asked to evaluate each video segment in accordance with 
procedures developed by Dr. Borod and colleagues (Borod et al., 2007; Canino, Borod, Madigan, 
Tabert, & Schmidt, 1999). The rater participants worked individually, in a quiet room, at a Dell 
Desktop computer. They were asked to evaluate the facial expressivity in each 15-second video 
segment.  The raters evaluated each video segment using a 7-point Likert scale (from “1” 
[minimal] to “7” [maximal]), in terms of facial movement (i.e., facial mobility), emotional 
expressivity (i.e., emotional variability, emotional frequency, and emotional intensity), and social 
engagement.  Each facial variable (e.g., emotional expressivity or emotional frequency) was rated 
individually until all video segments were completed.  Using the computer mouse, raters viewed 
each video segment, entered their value from 1-7, and advanced to the next video segment by 
clicking “play next.” All raters were able to watch the video segment up to three times, if needed, 
to make their rating.   
A set of approximately 1,500 video segments were rated, separately, in terms of the five 
facial variables of interest (i.e., Facial Mobility [FM], Emotional Variability [EV], Emotional 




was extensively trained on how to rate each variable in group sessions, and all raters carried out 
their ratings for each corresponding variable, individually, with no single rating session exceeding 
3 hours. Multiple rating sessions were required in order to complete all of the ratings for a single 
variable (i.e., approximately two weeks).  Once the ratings for the first variable were completed, 
the rater participants were then trained on the next variable, and those rating sessions began.  The 
variables were trained and rated in the following order: FM, EV, EF, EI, and SE.  Once the raters 
completed the training and rating procedures for all five variables, six new raters were recruited to 
undergo the exact same process as described above.  This was done four times (i.e., four groups of 
raters), due to the amount of video data that needed to be evaluated.  If we were to use one group 
of participant-raters to rate all of the data, we feared we would lose raters due to attrition.  It 
would have been too large of a task for any 6 rater participants.   
Rater cohorts.  Due to the large volume of poser-participant video data, we chose to use 
four groups of six raters (3 male, 3 female) to evaluate the poser-participant data.  The four 
groups of raters were comparable in terms of ethnicity (i.e., all Caucasian), age, and years of 
education.  Each rater cohort evaluated a subset of poser-participant data.  All 6 raters rated pre- 
and post-video data, PD patients (i.e., LSVT-LOUD; LSVT-ARTIC, and PDuntrx), healthy 
controls, and all monologue emotions (i.e., happy, angry, sad, and neutral).  Rater Cohort 1 was 
established first.  When the rater participants completed their ratings for all variables (i.e., FM, 
EF, EV, EI, and SM), a new cohort of raters was recruited and formed.  Each of the Rater Cohorts 
1-4 rated the variables in the order of FM, EF, EV, EI, and SE.  
Rater training procedures.  For each variable, all raters participated in an extensive 




training session leader) in Dr. Borod’s Emotion Laboratory.  First, the training session leader 
defined relevant terms and operationalized the variable on which they were to be trained, such as 
“Facial Mobility.” Second, the 7-point Likert scale that was used to make the actual ratings was 
reviewed and explained to the raters. Third, the training session leader described all of the 
different facial features of a face and how movement of such features (e.g., wrinkling of the 
forehead, widening of eyes, pursing of lips, etc.) should be attended to with respect to each facial 
rating, disregarding any extraneous head movements, tremors, or excessive blinking.  These 
descriptions were based on the literature regarding prototypical characteristics of facial expression 
(e.g., Ekman & Friesen, 1975; Izard 1983; Scherer, 1989) and were developed specifically for this 
project.  
Exemplar presentation.  For the next phase of training, raters were shown two 15-second 
exemplar video segments (i.e., one male and one female) which clearly represented each point on 
the scale (i.e., what a “1” would look like, what a “2” would look like, etc.), totaling 14 
exemplars.  Superlab v. 4.5 Pro (Cedrus Corporation) was used for all video stimulus presentation 
during variable training. The exemplar video segments and subsequent poser training materials 
consisted of digitized VHS data, of both PD and HC subjects, from previous pilot work by Borod 
and colleagues (Borod et al., 2007). The video exemplars used for training were previously 
evaluated by three judges, and only where there was very high agreement among the judges, was 
an exemplar to be used for training.  During exemplar presentation, each segment was shown 
without audio, and the training session leader explained each segment in terms of the 
characteristics that qualified it as being an example of a 1, 2, 3, etc. on the Likert Scale.  Two 




Conferencing.  After all exemplars were presented to the raters, a “Conferencing Stage” 
took place.  The training session leader presented 12 video segments that allowed for practice, 
ratings, discussion, and review.  These video segments were presented in a randomized order with 
respect to gender, group, and emotion.  Raters were asked to write down their rating on a sheet 
provided.  The ratings were then spoken aloud and shared with the group, so that the raters were 
able to see how their ratings compared to the ratings of the other 5 rater participants.  If all of the 
individual ratings were consistent with one another (i.e., not differing by more than 2 points), the 
next poser video segment was presented.  If discrepant ratings occurred (i.e., ratings that differ by 
greater than 2 points), a discussion was held among the group and opinions and thoughts were 
discussed.  The descriptions and instructions provided at the start of the training session were 
reinforced, and the experimenter focused the discussion on rating techniques that would 
encourage group agreement and consensus.  Once the discussion was over, raters were given the 
opportunity to watch the video segment again and re-rate it, as the discussion may have led them 
to a different evaluation of the video segment.  The experimenter recorded all of the raters’ 
original ratings and any ratings that changed after discussion.  This process continued for each of 
the 12 conferencing video segments.   
Practice ratings.  In the last stage of training, forty practice poser video segments were 
presented to the raters.  The raters were instructed to rate the segments individually and to write 
down their responses on the sheet provided.  No feedback or discussion was given during this 
stage of training.  After all ratings were complete, the training session leader calculated the 
average one-way random Intra-Class Correlations (ICC) for the 40 practice items.  This was done 
to ensure sufficient internal consistency among the raters.  Based on standards used in other 




agreement among raters’ responses (ICC ≥  .80). If the criterion was not met, additional training 
was continued until sufficient consensus was reached.  
Pre-Data Processing 
Poser video cleaning and segmentation.  All poser monologue videos, as originally sent 
from Colorado, were first inspected for any extraneous talking by or to the experimenter, long 
pauses without speech, and any additional extraneous video interruption.  These parts of the taped 
monologue sessions were removed using Corel Video Studio ProX 3 via a process we termed 
“cleaning.”  The remaining monologue were then split into 15-second segments for all 
participants and emotions. These “cleaned” and “segmented” video segments were then used as 





A significance level of p = .05 was used for all statistical tests.  The Bonferroni procedure 
was used to correct for multiple comparisons for all main effects (i.e., where there were greater 
than 2 levels) and interactions.   
Preliminary Analyses 
Evaluation of the distributions.  The 4 poser groups (i.e., LSVT-LOUD, LSVT-ARTIC, 
HC, and PD-untrx) were first inspected for normality using the Kolmogorov-Smirnov statistic 




Bivariate normality was assessed between group and monologue emotion using the Kolmogorov-
Smirnov test. The distributions for the 4 poser groups (i.e., LSVT-LOUD, LSVT-ARTIC, HCs, 
and PD-untrx) for each of the 4 monologue types (i.e., Happy, Angry, Neutral, and Sad) were 
normally distributed, except for the Sad monologue for the LSVT-ARTIC group. The overall 
percent of normally distributed bivariate data was 15/16 distributions, or 94%.  All observations 
in the sample for all combinations of variables were analyzed for multivariate normality (Stevens, 
1992). The data (i.e., 5 facial variables x 4 monologue types x 2 time points = 40 distributions) for 
each of the 4 treatment groups (i.e., 160 distributions) were analyzed for normality using the 
Kolmogorov-Smirnov test. The percentage of normally-distributed distributions for each 
treatment group were as follows: LSVT-LOUD = 88%, LSVT-ARTIC = 75%, PD-untrx = 93%, 
and HCs = 78%. 
The data (i.e., 5 facial variables x 4 monologue types x 2 time-points) for each of the 4 
poser groups were then examined for multivariate homoscedasticity using Levene’s test. Eighty-
eight percent of the distributions (i.e., 140/160) demonstrated homogeneity of variance (i.e., p > 
.05).  For these distributions, all normal probability plots (i.e., Q-Q plots) were visually inspected 
for variability and outliers (Mertler &Vannatta, 2005).  
Taking all three of these analyses into consideration, we felt very comfortable proceeding 
with parametric statistical procedures as the Analysis of Variance (ANOVA) procedure is robust 
to violations of homoscedasticity (e.g., Lix & Keselman, 1998; Mertler & Vannatta, 2005; 
Ramsey, 1994).  
Poser group characteristics.  Posers were stratified and matched across the 3 




education, stage of disease, and gender.  Posers in the HC group were carefully matched to the 3 
experimental groups by the same factors.  Demographic and clinical information for all four poser 
groups can be seen in Table 1.  A one-way ANOVA was performed for each of the demographic 
factors.  The analyses revealed that there were no statistically significant differences among the 
four poser groups for age, F(3,76) = 1.21; p = .32, and education, F(3,76) = 1.76; p = .162.  
Further, there were no statistically significant differences among the three PD groups for stage of 
disease, according to the Hoehn and Yahr scale, F(2, 59) = .248; p = .781, and time since 
diagnosis, F(2, 59) = .021; p = .97.  Finally, the Chi-square test revealed that there were no 
statistically significant differences between the PD and HC groups for gender, X2 (2) = .321, p > 
.571. 
Rater group characteristics.  Four groups of 6 raters (3 male and 3 female) were selected 
to rate the poser facial expressions. The mean age for the 12 male raters was 21.7 years and 21.7 
years for the 12 female raters.  The average years of education for the male and female raters was 
14.3 and 14.7, respectively.  Rater group demographic characteristics (i.e., gender, age, and 
education) are summarized in Table 2. 
Inter-rater reliability. Four groups of 6 raters (N = 24) were trained to rate each of the 5 
facial expressivity variables: Facial Mobility (FM), Emotional Frequency (EF), Emotional 
Intensity (EI), Emotional Variability (EV), and Social Engagement (SE).  For each group of four 
raters, we analyzed the group’s average One-way Random Intra-Class Correlations (ICCs; Shrout 
& Fleiss, 1979) for the 12 conferencing ratings and for the 40 practice ratings (see Methods 
section for details).  The ICCs can be seen in Table 3.  The inter-rater agreement for each training 




ratings.  The correlations showed that agreement among the raters was high for all variables.  All 
correlations for conferencing and practice ratings were ≥ .85.  The conferencing ICCs were 
always higher than the practice ratings for each variable.  This is to be expected because the 
conferencing ratings were performed aloud as a group.  When raters rated the practice items, 




Statistical analyses by aim. 
Aim 1.  Determine whether the Lee Silverman Voice Treatment (LSVT- LOUD) 
affects facial emotional expression in individuals with Parkinson’s disease (PD), during the 
recollection of past emotional experiences, as compared to 3 demographically-matched 
groups: Untreated PDs, HCs, and a PD group receiving an equivalent treatment. In order to 
examine the effect of Treatment (i.e., LSVT-ARTIC, LSVT-LOUD, PD-untrx, and HC) on facial 
emotional expression, we performed a 4 x 4 x 2 (Group [LSVT-LOUD, LSVT-ARTIC, PD-untrx, 
and HC] x Monologue Type [Angry, Sad, Happy, and Neutral] x Time [Pre and Post]) mixed-
model ANOVA, separately, for each of the five facial variables (i.e., FM, EV, EF, EI, and SE).   
  We expected to find an interaction between Group and Time, demonstrating that the 
LSVT-LOUD group improved post-treatment compared to the 3 control groups.  We did not find 
a significant Group x Time (ps > .05) or Group x Time x Monologue Emotion (ps > .05) 
interaction for any of the 5 facial variables. These results indicate that there was no significant 
change in the facial expressivity of PDs after being treated with LSVT-LOUD.  However, as 
expected, the facial expressivity of the LSVT-ARTIC and the untreated groups (untreated PDs 




The results of the ANOVAs indicated that there were no significant main effects for 
timepoint (ps > .05); there were no significant differences between Time 1 (Pre) and Time 2 
(Post) for any of the 5 facial expressivity variables.  
Significant main effects were found for Group for EF, F(3,72) = 4.4, p = .007; SE, F(3, 
72) = 4.17, p = .009; and FM, F(3, 72) = 3.13, p = .031.  For the measures of EF and SE, the HC 
group was rated as having greater emotional expressivity and social engagement compared to the 
3 PD groups.  For FM, LSVT-ARTIC was the only PD group that was significantly different from 
the HC group.  However, the average facial ratings for LSVT-LOUD and PD-untrx were lower 
than the HC group although they did not reach significance.  These results are summarized in 
Figure 1.  Further, although not significant, a trend towards a main effect for Group was found for 
EI, F(3, 72) = 2.54, p = .06.  A comparison of the group means demonstrated the same pattern as 
above. As expected, none of the facial ratings for the PD groups (LSVT-LOUD, LSVT-ARTIC, 
or PD-untrx) were significantly different from one another for any of the 5 facial expressivity 
variables.  
Significant within-subject main effects were found for Emotion for each of the 5 facial 
expressivity measures, FM, F(3, 70) = 11.51, p = .000; EI, F(3, 70) = 7.46, p = .000; EF, F(3, 70) 
= 7.94, p = .000; EV, F(3, 70) = 11.64, p = .000; and SE, F(3, 70) = 23.1, p = .000.  The pairwise 
comparisons for the main effects of Emotion are summarized in Figure 2.  Overall, for each 
measure, the order from highest to lowest ratings was Happy, Angry, Sad, and Neutral. In terms 
of significance, posers’ Happy monologues were rated significantly higher than posers’ Neutral or 
Sad monologues for each of the 5 facial expressivity variables. For EI, EF, and SE, posers’ Happy 




rated as having significantly greater emotional expressivity (i.e., EF, EV, and EI) than the Neutral 
monologues; however, the reverse was found for FM and SE, with neutral monologues rated 
significantly higher than Angry monologues.  Further, Angry monologues were rated as having 
significantly greater EV and SE as compared to Sad monologues. Finally, for SE, Neutral 
monologues were rated significantly higher than Sad monologues. 
Aim 2.  Explore whether the emotional intensity of one’s facial expression relates to 
one’s experience of emotion (i.e., how intensely participants experience emotion) during the 
production of monologues recalling past emotional experiences.  Does the relationship 
between emotional experience and expression differ between PDs and HCs? We performed 
Pearson Product-Moment Correlations, separately, for the PD and HC groups, for the facial 
expressivity ratings of emotional intensity (EI) versus each of the three self-reported emotional 
experience measures: 1) immediate experience (i.e., how subjects felt, emotionally, immediately 
after talking about an emotional event [i.e., “the monologue”]), 2) accuracy of experience (i.e., 
how accurately they felt they expressed the emotion during each monologue), and 3) intensity of 
experience (i.e., how intensely they felt the emotion during the monologue). These correlations 
were performed on the ratings of Happy, Angry, and Sad monologues, separately, as well as for 
pre and post ratings.  If a correlation was significant, we performed the Fisher r-to-z 
transformation (Chapman & Chapman, 1998) to determine if one group (i.e., PDs or HCs) had 
stronger correlational effects than the other.  The results of all of the correlational analyses are 
presented below and summarized in Table 4.   




For the PD group, ratings of facial emotional intensity were positively correlated to the 
experience of each emotion, both at Time 1 (Pre) and Time 2 (Post). Only 6/18 correlations were 
significant; however, out of the 6 possible correlations for the Sad emotion, 5/6 were significant 
(see Table 5 for a summary of results).  The correlations between the expression of sadness and 
the experience of sadness were significantly correlated (r = .40, r = .47, r = .24, r = .29, r = .22; 
ns., r = .19).  The emotional intensity of posers’ faces, while producing a Sad monologue, was 
positively correlated to their feelings of emotional intensity during the monologues and to how 
they felt immediately after the monologues.  This pattern of results is seen at Time 1 (Pre) and 
Time 2 (Post), although the correlations are not as strong at Time 2.  Facial expressions of sadness 
were less related to perceived accuracy in producing the emotion.  The correlation between facial 
EI for sadness and self-assessed accuracy was only significant at Time 2 (i.e., r = .29) as opposed 
to Time 1 (i.e., r = .19).   
Only 1/6 total possible correlations was significant between the experience of happiness 
and facial expressivity for happiness.  For Time 1, there was a significant positive correlation 
between the expression of happiness and perceived accuracy in displaying happiness (r = .23). 
This finding is difficult to interpret given the overall findings of 5/6 non-significant correlations 
for the happy monologue and that the same relationship was not present at Time 2. The positive 
correlations between the experience of Anger and the facial expressivity for Anger did not reach 
significance.  
Healthy-Control correlations. 
For the Healthy Control group, 12/18 of the correlations were positive.  Three significant 




and the experience of Anger (i.e., Intensity, Accuracy, and feelings “Immediately” following the 
monologue) for Time 1. These findings suggest that, for Angry monologues, greater 
demonstration of facial EI was related to a reduction in the experience of Anger intensity.  
Conversely, and more likely, these findings could also suggest that greater experiences of Anger 
were related to reductions in facial EI.  It is unclear as to why Time 2 did not show a similar 
correlational pattern (see Table 5 for a summary of the results).  One inverse correlation (r = -.03) 
was found between the expression of happiness and the experience of happiness, and one was 
found between the experience of happiness and perceived accuracy of happiness (r = -.27). Since 
neither of these correlations reached significance, these results cannot be explained in a 
meaningful way.  Finally, none of the remaining positive correlations for the Happy or Sad 
condition reached significance. 
Correlation comparison between groups. 
In order to examine if there were stronger correlational effects between the PD and HC 
groups, the Fisher r-to-z transformation (Chapman & Chapman, 1998) was used to test the 
significance between the group correlations. A summary of these analyses can be seen in Table 6.  
The results indicate that the correlations for the HC group were significantly greater for the Angry 
emotion at Time 1 than were those for the PD group.  Specifically, we found a significant 
difference in the relationship between the facial expressivity of Anger and experienced EI of 
Anger (p = .02), perceived accuracy of Anger (p = .01), and experience of Anger immediately 
following the monologue (p = .00).  Likely driving these results are the significant inverse 




for HCs.  These findings indicate that there is a significant difference in the relationship between 
experienced and expressed Anger between PDs and HCs. 
Group differences in emotional experience. 
We also examined whether there were differences in emotional experience between PDs 
and HCs.  A 2 x 3 x 2 (Group [PD and HC] x Monologue Emotion [Angry, Happy, and Sad]) x 
Gender [Male and Female]) mixed-model ANOVA was performed for each of the three emotional 
experience measures (i.e., “Intensity” of Experience, “Accuracy,” and Experience “Immediately” 
Following).  Even though the literature (e.g., McCabe et al., 2010) typically does not find 
differences in emotional experience between PDs and HCs, we examined this in our own sample 
of PD and HC participants. The results from these ANOVAs are summarized in Table 7.  
As expected, we did not find a main effect of Group (ps > .05) or any interaction between 
Group and Emotion for any of the 3 experience variables.  These findings are comparable with 
previous research (e.g., McCabe et al., 2010) that suggests that PDs and HCs experience emotion 
similarly.  However, we did find a main effect for Emotion for Intensity, F(2, 66) = 8.67, p = 
.000, Immediate, F(2, 66) = 14.2, p = .000, and Accuracy, F(2, 66) = 3.21, p = .047.  Pairwise 
comparisons indicate that Sad emotions resulted in significantly higher experienced EI, perceived 
accuracy, and greater feelings immediately following the monologue compared to Angry 
emotions.  Posers reported feeling significantly greater intensity for Sad monologues than Happy 
monologues. Immediately following the monologue, posers felt significantly more emotion after 




 Aim 3.  Examine whether there are gender differences in how men and women view 
facial emotional expressions of the same and opposite gender.  We conducted a 2 x 2 x 2 x 4 
(Rater Gender [Male and Female] x Poser Gender [Male and Female] x Time [Pre and Post] x 
Monologue Type [Angry, Happy, Sad, and Neutral]) mixed-model ANOVA for each of the five 
facial variables (i.e., FM, EV, EF, EI, and SE). The Bonferroni procedure was used to correct for 
multiple comparisons for all main effects and interactions.  See Table 8 for a summary of results.  
The results of the gender analyses revealed significant main effects for Rater Gender for 
EF, F(1, 74) = 5.90, p = .018; EV, F(1, 74) = 56.1, p = .000; and EI, F(1, 74) = 8.64, p = .004 (see 
Figure 4).  Men rated posers as having significantly greater emotional expressivity (EF, EV, and 
EI) than did the female raters.  However, women rated the posers as having greater Social 
Engagement compared to male raters [SE, F(1, 74) = 18.7, p = .000].  For the control variable of 
FM, both genders were rated as having equivalent amounts of FM (p > .05).  Further, we found an 
interaction between poser gender and rater gender for SE, F(1, 74) = 10.6, p = .002; see Figure 4.  
Although both male and female raters judged female posers to be more facially expressive than 
male posers, female posers were rated as significantly more expressive than men by female raters 
than by male raters (see Figure 6).  For EV, we found a 3-way interaction among poser gender, 
rater gender, and emotion (Figure 14), F(3, 74) = 3.55, p = .027.  However, after the Bonferroni 
correction, the effect did not reach significance (ps > .05).  We also discovered a 4-way 
interaction among poser gender, rater gender, emotion, and time, for EF, F(3, 74) = 3.74, p = 
.012, and FM, F(3, 74) = 6.09, p = .001.  We did not make any predictions regarding the 
interaction of time and valence.  However, in an attempt to explore these findings, we visualized 
the data by creating Figures 5a & 5b and 6a & 6b.  Unfortunately, the figures did not yield any 




posers, were rated as having greater EF and FM for Happy Monologues; of note, this effect was 
greatest when rated by female raters at Time 1. 
For all of the facial expressivity variables of EF, EV, EI, SE, and FM, we found an 
interaction between poser gender and emotion (ps > .05).  After pairwise comparisons and a 
visual inspection of the data (see Figures 7-11), it is clear that female posers were rated higher 
than male posers, in general.  However, when the ratings were broken down by monologue 
emotion, there were some emotions where male and female posers did not differ significantly in 
terms of how they were rated.  This was especially true for the Sad monologues. For instance, for 
EF, female posers were rated as significantly more expressive than male posers during Happy, 
Angry, and Neutral monologues but not for the Sad monologues.  These findings, however, do not 
represent true interactions between poser gender and emotion, rather, they are demonstrative of 
regression towards the mean and greater variability among the female posers’ ratings.  
We found a significant main effect for Poser Gender for each of the 5 facial expressivity 
variables: EF, F(1, 74) = 21.9, p = .000; EV, F(1, 74) = 22.1, p = .000; EI, F(1, 74) = 24.7, p = 
.000; SE, F(1, 74) = 6.39, p = .014; and FM, F(1, 74) = 20.9, p = .000.  For each of the facial 
expressivity variables, female posers were rated as having significantly more facial emotional 
expressivity and facial mobility as compared to male posers.  The group means can be seen in 
Figure 12. 
There was a significant main effect of emotion for EF, F(3, 74) = 11.6, p = .000; EV, F(3, 
74) = 11.7, p = .000; EI, F(3, 74) = 8.27, p = .000; SE, F(3, 74) = 20.53, p = .000; and FM, F(3, 
74) = 14.5, p = .000.  These results are summarized in Figure 13.  Posers were rated as 
significantly more facially expressive during Happy monologues compared to Sad (p < .05), 




EI, and FM, posers were rated as significantly more facially expressive during Sad monologues as 
compared to Neutral monologues (p < .05).  For EV, EI, and FM, Angry monologues produced 
significantly more facial expressivity than Neutral monologues (p < .05).   
We did not find a main effect for time (p > .05) or any two-way interactions for time x 
poser gender (ps > .05), time x rater gender (ps > .05), or time x emotion (ps > .05) for any of the 
facial expressivity variables.  
CHAPTER IV 
Discussion 
Through various configurations of facial muscles, individuals convey a wealth of 
emotional information.  Parkinson’s disease is one of few illnesses that is marked by the 
decreased ability to communicate emotions facially.  The research conducted in this project 
examines the ways in which the facial communication channel is compromised in PD and 
explores the potential benefit of LSVT-LOUD in remediating hypomimia. 
 
Summary of Findings 
LSVT-LOUD treatment effects. 
Contrary to our predictions for Aim 1, we did not find an effect of LSVT-LOUD treatment 
on PDs’ facial emotional expressions.  There could be some reasons for this.  In 2003, Spielman 
and colleagues first reported the preliminary data and results they obtained from treating 22 PD 
patients with LSVT-LOUD.  The PD patients who received LSVT-LOUD were rated as having 
greater facial mobility and higher levels of social engagement than a PD group receiving 
respiratory treatment (Spielman et al., 2003).  It is important to point out the differences in facial 




al. (2003) study, PD patients were asked to “talk about anything you want for the next 20-30 
seconds.”  This resulted in self-generated speech and facial expressions that were not necessarily 
emotional.  Further, the content of their monologue could have been in the future, present, or past.  
The methods utilized in the current study asked PD patients to recall an emotional event that 
happened to them previously and to talk about it.  Our task involved retrieval of an 
autobiographical event, holding the retrieved memory in the attention window (Jacobs et al., 
1995), reconstruction of stored internal representations (Dudai, 2002), sequencing, recruitment of 
limbic regions, and reporting what happened.  Further, evidence suggests that the recollection of a 
visual scene results in the activity of visual cortices (Wheeler, Petersen, & Buckner, 2000).  In 
sum, the task used in the current study was neurocognitively demanding, requiring the activation 
and integration of numerous brain regions.  It is plausible that our task was more challenging than 
the task from the Spielman et al. (2003) study and, thus, less amenable to the therapeutic effects 
of LSVT-LOUD.  
Posed and spontaneous facial emotional expressions rely on relatively distinct 
neuroanatomic pathways (e.g., Borod, Haywood, & Koff, 1997) and, therefore, can be affected in 
PD differently.  Spontaneous facial expressions are controlled by subcortical regions, whereas 
voluntary/posed facial expressions are controlled by cortical areas in the frontal lobe (e.g., Blair, 
2003; Borod & Koff, 1984).  It has been postulated that the facial expressivity benefits gained 
from LSVT-LOUD might be due to improved motoric functioning, therefore, spontaneous facial 
expressions, not posed, would improve after LSVT-LOUD.  The improvements in spontaneous 
expressions during conversational speech seen in Spielman et al. (2003) support this theory.  
However, does the current task of recalling a previously experienced emotional event result in 




it required greater neurocognitive recruitment than Spielman’s (2003) task. In a compromised 
population, such as PD, it’s plausible that our emotional monologue task required greater 
cognitive effort (i.e., increased neurocognitive recruitment) than it did for the HCs.  Increased 
cognitive activity has been shown to reduce emotional processing (Blair, Smith, Mitchell, 
Morton, Vythilingam, et al., 2007). As such, the cognitive demands of the emotional monologue 
task may have resulted in an overall reduction in emotion processing for the PD group as 
compared to other emotional tasks.   
Although not an aim of the current study, our results indicate that the PDs in our sample 
demonstrated impaired facial expressivity relative to HCs.  Emotional Frequency and Social 
Engagement were significantly reduced in the PD groups compared to HCs.  Despite seeing 
reductions in all PD groups, only the LSVT-ARTIC group was significantly decreased on the 
measure of Facial Mobility.  Similarly, all three PD groups demonstrated a reduction in 
Emotional Intensity compared to the HCs; however, the difference did not reach significance. 
Effect of Monologue Emotion. 
Although we did not have specific predictions about how different emotions would be 
perceived by raters, we found that for all of the facial expressivity variables, Happy monologues 
were rated significantly higher than Sad monologues across all participant groups. 
In general,1 there was a pattern of Happy > Angry > Sad > Neutral, with the exception of 
SE, where Neutral > Sad.  Generally, these findings legitimized the Neutral condition as our non-
emotional control variable.  Using a Neutral condition as a non-emotional control, we expected 
                                                          




that ratings of facial emotional expressivity would be lower for neutral monologues compared to 
the emotional monologues, and this was the case.   
As described in the previous paragraph, there was an overall pattern of facial emotional 
expressivity such that posers were rated as more expressive as a function of monologue type as 
follows:  Happy > Sad > Angry > Neutral.  These results are consistent with the preponderance of 
findings in the literature regarding emotional valence, such that positive facial expressions of 
emotion are judged as more expressive than are negative expressions (e.g., Borod et al., 2004).  
These results may be best understood in terms of positivity theory and socioemotional selectivity 
theory.  According to positivity theory, older adults are driven to reduce the amount of energy and 
time spent on negative events, particularly unpleasant social encounters (Carstensen, Fung, & 
Charles, 2003).  According to socioemotional selectivity theory, when reliving negative emotional 
events from the past, older adults report less negative emotion and greater positivity than younger 
adults (Charles & Carstensen, 2008).  The emotional expressions of the posers in our study are in 
line with these findings, such that older adults were more expressive for positive emotions (e.g., 
Happy) than negative emotions (e.g., Sad and Angry).  As expected, the non-emotional control 
condition of Neutral resulted in the least amount of facial expressiveness.   
Group differences: The relationship between experienced and expressed emotion. 
Since evidence suggests that PDs experience emotion in a similar way as HCs (e.g., Mikos 
et al., 2009), yet have emotional expression deficits, we hypothesized that the correlation between 
experienced and expressed emotion would be lower for the PDs than for the HCs.  However, we 
did not see a pattern in the correlation matrix to support this hypothesis.   
For the PD group, the correlations between the expression of sadness and the experience 




monologue, was positively correlated with their feelings of Emotional Intensity during the 
monologues and how they felt Immediately following the monologue.  Facial expressions of 
sadness were less related to Accuracy of experience, since only 1 of the 2 correlations was 
significant.  
The literature suggests that PD patients with hypomimia can be perceived as unhappy and 
depressed (e.g., Pentland, Gray, Riddle, & Pitcairn, 1988).  It is possible that raters perceived PD 
posers in our sample as appearing depressed or unhappy.  This could have led to higher 
correlations between the experience/expression of sadness compared to the other emotions.  All 
posers in this sample were screened using the BDI, and any individual meeting the criterion for 
severe depression was excluded from participation.  However, it is unknown if the HCs and PDs 
differed in terms of depression.  As such, we ran follow-up analyses comparing BDI scores 
between PDs and HCs using the independent samples t-test.  We found that the PDs and HCs 
differed significantly for the BDI (PDs [?̅? = 8.8] and HCs [?̅? = 2.6]), t (1, 78) = 4.47, p < .001 (see 
Figure 15).  It has been previously reported that depressed patients have a difficult time 
expressing positive facial emotions (Jaeger, Borod, & Peselow, 1984) and display more intense 
sad emotions (Mergl et al., 2005).  It is possible that the higher BDI scores represent sub-clinical 
depression in the PD group and are moderating the higher correlations between the expression 
and experience for sadness.  
We expected to see a moderate/high correlation between the experience of emotion and 
the expression of emotion in the HC group.  We found, mostly, low/moderate positive 
correlations that were not statistically significant for the Happy and Sad monologues.  However, 
at Time 1, there was a significant inverse correlation between the expression/experience of anger 




significant difference between the two group’s correlations for Angry monologues, such that the 
correlations for the HCs were lower than the correlations for the PDs.  Research by Comblain, 
D’Argembeau, and Van der Linden (2005) found that older adults tended to reappraise negative 
events in a more positive light than did younger adults.  Since our population of posers was made 
up of older individuals, it is possible that our HC group also reappraised negative events more 
positively.  Alternately, the HC group could have been subconsciously acquiescing to social 
display rules.  According to Ekman and Friesen (1969), social display rules are the “learned, 
culture-specific rules governing the management and control of emotional expression depending 
on social circumstances.”  Buck et al. (1992) found that the expression of negative emotions is 
inhibited or reduced when in the presence of an unfamiliar person.  It is plausible that the HCs 
were experiencing intense anger, but due to the presence of an unfamiliar experimenter in the 
room, HCs reflexively masked their facial expressions of anger.  In support of this theory, we did 
not find the same pattern of correlations for Anger at Time 2.  It is possible that the posers were 
more familiar and comfortable with the experimenter at Time 2, thus, attenuating the effect of the 
presence of an unfamiliar person.   Further, it makes sense that PD patients did not demonstrate 
the same adherence to display rules as HCs.  Individuals with PD have nonverbal communication 
deficits.  In the presence of others, PD patients’ facial expressions are masked; therefore, facial 
and verbal feedback from others are perceived and interpreted differently, if not more negatively.  
Oftentimes, PD patients feel excluded from conversation, leading to feelings of loneliness and 
isolation (Miller et al., 2006).  Due to these feelings of social isolation, even in the presence of 
others, it is possible that individuals with PD do not interpret the social scenario as one that 
requires emotional monitoring or social display rules.  Further,  research suggests that patients 




patients have demonstrated a decreased ability to accurately perceive theory of mind tasks when 
compared to young and elderly controls (e.g., Saltzman, Strauss, Hunter, & Archibald,  2000).   
Taken together, evidence suggests that PD patients may not be as susceptible to the effects of 
social display rules as HCs. Therefore, this could explain the discrepant facial expressivity 
findings for HCs when producing angry monologues. 
We compared the PD and HC groups on the 3 measures of emotional experience: 
“Emotional Intensity” felt during the monologue, their feelings “Immediately Following” the 
monologue, and the extent to which they felt they produced the emotion “Accurately.”  As 
hypothesized, there were no significant differences between the HCs and PDs for evaluations of 
emotional experience; both groups experienced the monologue emotions similarly.  
We did, however, find a main effect of emotion.  Posers experienced anger to a lesser 
degree in Emotional Intensity and to a lesser degree Immediately Following the monologue 
compared to their experience for Sad monologues.  Also, Immediately Following the Angry 
monologues, posers experienced a lesser degree of emotion than after happy monologues.  It is 
possible that posers found it more difficulty in becoming angry as compared to other emotions.  
Again, this can be best understood in terms of social display rules. Posers may have 
subconsciously felt it socially inappropriate to display anger in the presence of the experimenter.  
As such, they had greater difficulty in feeling angry from a past event. The differences in the 
degree to which varying emotions are relived is an area for further research.  
Gender analyses. 
One of the major aims of this study was to examine how facial masking in PD is evaluated 
by others and how these judgments differ based on the gender of the individual and the gender of 




expressive compared to opposite-gendered posers; this prediction was partially substantiated. Our 
gender analyses revealed that for each of the facial emotional expressivity variables (i.e., EF, EV, 
and EI), female posers were rated as having significantly more facial expressivity and Facial 
Mobility as compared to male posers.  This finding corroborates the results from previous 
research that has found that women are more facially expressive than men (e.g., Kring & Gordon, 
1998).  Although all raters judged female posers to be more facially expressive, as expected, 
female posers were rated as significantly more expressive than male posers by only female raters.  
Given that women are better at detecting facial emotions (e.g., Montagne, Kessels, Frigerio, de 
Haan, & Perrett, 2005) and that they are more facially expressive (e.g., Brody & Hall, 1993; 
Kring & Gordon, 1998) than are men, it is not surprising that we found that female posers were 
rated as significantly more facially expressive by female raters.   
Our gender analyses revealed that men and women rate facial expressions differently.  For 
the facial expressivity measures of Emotional Frequency, Emotional Variability, and Emotional 
Intensity, male raters rated posers as more facially expressive than did female raters.  This is a 
surprising finding.  Given that men are less sensitive to emotional facial expressions (e.g., 
Montagne et al., 2005), we would expect that if any rater-gender effect occurred, it would be that 
women rated posers as being more expressive.  We did, however, find that female raters rated 
posers as being more socially engaged than did the male raters.  Interestingly, male and female 
raters rated all of the emotional expressivity (i.e., EF, EV, EI) variables differently, however, they 
rated measures of Facial Mobility similarly for both male and female posers.  This lends further 







One limitation of the present study was that the facial expressions of the posers yielded a 
small range of rated values.  Very few posers were rated as 6s or 7s.  One reason for this could be 
due to the demographic region from which these participants were recruited.  As stated in the 
Methods section, all poser participants were recruited from the Colorado area.  It is plausible that 
variations in emotional expressivity exist among regions in the United States, such that Mid-
westerners are more likely to dampen negative expressions of emotion in comparison to those in 
the NY Metro area.  Further, those living in NY Metro areas may be less frequent in showing 
positive facial expressions (e.g., saying hello, smiling, etc.) compared to other regions in the US.   
It is possible that the emotional expression differences could be a result of how strongly 
individuals adhere to social display rules and propriety.  We hypothesize that decreases in facial 
expressivity from individuals within these regions may have resulted in a floor effect within the 
dataset, such that differences between PDs and HCs could not be captured. While this explanation 
is purely speculative, further investigation into regional differences in facial emotional expression 
would be of interest.  
Another limitation of the present study is that sub-clinical depression may have been 
present affecting facial expressivity.  Future research should try to take into account any sub-
clinical depression present in the PD groups (e.g., via covariate analyses) that could account for 
any blunted facial affect.  Further, matching the HC group to the PD group on their score on the 
Beck Depression Inventory - II could better control for any underlying sub-clinical depression.   
Rather than using a system like the Facial Action Coding System (FACS; Ekman & 
Friesen, 1978), the current study examined facial emotional expressions as evaluated by human 




therefore, could be considered not as empirically rigorous, despite high inter-rater reliability.  
However, human ratings/evaluations have greater ecological validity and improved 
generalizability of results.  Future research may want to use both methods of evaluation within a 
given sample.   
Implications and Conclusion 
Hypomimia limits PD patients’ ability to express themselves accurately and affects the 
ability to navigate their social world.  Communication and inadequate social relationships are two 
of the most frustrating complaints among PD patients (e.g., Borod et al., 1990).  This leads to 
misattributions by others, PD patients feeling embarrassed to communicate (Miller, Noble, Jones, 
& Burn, 2006), loss of interest from caregivers (Gunnery et al., 2016), and overall decline in 
quality of life for the individuals affected.  Therefore, it is imperative that we understand the 
nature of such expressivity deficits in order to develop tailored rehabilitative strategies and to 
further our scientific understanding of emotional expression.   
One of the major aims of this study was to examine how facial masking in PD is evaluated 
by others and how these judgments differ based on the gender of the patient and the gender of the 
observer.  We garnered further support to the previously demonstrated finding that women are 
more facially expressive than men.  In line with our hypothesis, female raters rated female posers 
as more expressive than male posers.  However, we did not find the same congruency effect for 
male raters rating male posers; this is likely because female facial expressivity was higher than 




Contrary to what we predicted, we did not find evidence to support that LSVT-LOUD 
improves facial masking in PD patients.  However, our study has several important clinical 
implications.  We provided additional evidence to support previous findings (e.g., Borod, Rogers, 
et al., 2008) that PDs experience emotion similarly to HCs, despite hypomimia symptomology.  
Expressivity deficits in PD due to depression, sub-clinical or otherwise, require further 
examination.  Given that hypomimia is a feature of both depression and PD, diagnosing 
depression in PD can be difficult.  Future research should focus on factors related to depression, 
self-worth, and social isolation and on how these factors interact with the hypomimia 
symptomology in PD.  Understanding all dimensions of these factors will help patients with PD 
maintain an active role in our social world.  The results of the current study further characterize 
the facial deficits seen in PD and explore the possibilities for clinically meaningful future 
research.  








(Borod, Welkowitz, & Obler, 1992) 
 




Gender:     Male      Female 
Age: ______   Birthdate: ____________ 
Ethnicity (What is your ethnicity?):  _______________________ 
Education:  ______________________ 
 
           First language: ________________ 
          (If anything other than English, from what age have you been speaking Eng.?  ___ years-old) 
  
2. Medical History: 
 
Have you ever had any neurological problems (e.g. stroke, tumor, head injury etc.)?    
  Yes          No       
 
Have you ever seen anyone for emotional problems (e.g. counselor, psychiatrist, psychologist, member of 
the clergy) or have you ever had any diagnosable psychiatric disorders (such as depression, substance abuse, 
bipolar disorder, etc.)?             Yes          No 
 
Have you ever been hospitalized for any psychiatric problems or for substance abuse?    
  Yes          No    
    




Have you ever had any problem with your vision?           Yes          No 
If yes, what was the problem and how long did it last? 
____________________________________________________________________________ 
           
Do you have 20/20 vision with or without correction?      Yes          No 
 
3. Neurological History: 
 
Have you ever had any of the following diseases? 
  
      Alzheimer’s Disease 
      Arteriosclerosis 
      Congenital Abnormalities 
      Creutzfeldt - Jakob disease 
      Dementia 
      Epilepsy 
      Huntington’s Chorea 
      Korsakoff’s Syndrome 
      Multiple Sclerosis 
      Normal Pressure Hydrocephalus 
      Parkinson’s Disease 




      Previous CVA 
      Pseudobulbar Palsy 
      Subcortical Motor Disorders 
  Schilder’s Disease 
  Seizures 
      Wilson’s Disease      
      Other neurological disorders:  ______________________________________________ 
 
 
             Have you ever had a head injury or head trauma?  Did you lose consciousness?  
 ____________________________________________________________________________ 
 ____________________________________________________________________________ 
            ____________________________________________________________________________ 
 
4. Learning Disability: 
  
 Do you have a history of a learning disability?    Yes          No 
 
 Was it ever diagnosed by a professional?    Yes          No 
 
 Do you or have you had serious problems  
   with reading, writing, spelling, or arithmetic?   Yes          No 
 
5. Substance Use:  
 
Have you ever considered cutting down on your alcohol intake?   Yes          No 
 
Do people annoy you by criticizing your drinking?     Yes          No 
 
Have you ever felt bad or guilty about your drinking?     Yes          No 
 
Have you ever had an alcoholic drink first thing in the morning  
(eye-opener) to steady your nerves or get rid of a hangover?    Yes          No 
 
Have you ever used recreational drugs?      Yes          No 
 
Has drug use ever interfered with your daily functioning?    Yes          No 
 
6. Handedness:  
  
Do you consider yourself to be:     Right handed   Left handed       Ambidextrous? 
 
In childhood or as an adult, did you ever switch, or were you ever forced to switch your handedness?
   Yes          No 
 
Are (or were) either of your parents or any of your full siblings left-handed or ambidextrous? 






Demographic Characteristics for Poser Participants (N=82) 
 
Note.  BDI = Beck Depression Inventory (<15 mild depression, 15-30 moderate depression, >30 severe depression; 
Beck et al., 1996); MMSE = Mini Mental Status Examination (a 30-point scale where 20-24 = mild dementia, 13-20 
= moderate dementia, and < 12 indicates severe dementia; Folstein et al., 1975); Hoehn-Yahr stage of disease ranges 
from 0 (minimal) to 6 (most severe; Hoehn-Yahr, 1967); Means are presented for each group. Standard Deviations 





































































































































































Demographic Characteristics for Rater Participants (N=24)  
 
 Age ?̅?s (in years) Education  ?̅?s (in years) 


























































21.7        
(3.8) 
21.7           
(2.5)   
21.7            
(3.5) 
14.3        
(1.1) 
14.7          
(0.4) 
14.3        
(1.1) 
       
 







Interrater Reliability: Intra-class Correlations for Conferencing and Practice Ratings 
 
  Training Variables 
  
    
COHORT 1 FM EV EF EI SE 
  
Conferencing 0.96 0.90 0.92 0.98 0.98   
Practice Ratings 0.92 0.85 0.91 0.94 0.93   
COHORT 2 FM EV EF EI SE 
  
Conferencing 0.93 0.90 0.94 0.92 0.95   
Practice Ratings 0.86 0.89 0.88 0.92 0.86   
COHORT 3 FM EV EF EI SE 
  
Conferencing 0.95 0.90 0.95 0.95 0.95   
Practice Ratings 0.91 0.88 0.88 0.91 0.90   
COHORT 4 FM EV EF EI SE 
  
Conferencing 0.96 0.89 0.94 0.94 0.97   
Practice Ratings 
 
0.92 0.88 0.91 0.91 0.93   
        
 
Note. FM = Facial Mobility; EV = Emotional Variability; EF = Emotional Frequency; EI = Emotional Intensity, SE = 
Social Engagement. The ICCs for conferencing are based on the original rating evaluation given by each rater, not the 








Group by Time by Emotion (4 x 2 x 4) ANOVA for Emotional Expression, Significance of Effects 
 
 EF EV EI SE FM 
Emotion (4) < .001** < .001** < .001** < .001** < .001** 
Time (2) .457 .619 .621 .542 .882 
Group (4) .007* .102 .063 .009* .031* 
Emotion x Group .490 .546 .936 .705 .470 
Time x Group .758 .657 .316 .660 .679 
Emotion x Time .505 .853 .744 .870 .856 
Emotion x Time x 
Group 
.149 .480 .519 .621 .532 
      
 


























Happy .37 .26 - .03  .16 - .27 .02 
Angry - .51* - .58* - .68*  .03 .28 - .13 
Sad .30 .29 .23  .02 .07 .17 
PDs (all 3 
groups) 
Happy .11 .23* .14  .14 .16 .19 
Angry .08 .02 .21  .02 .11 .04 
Sad .40** .19 .47**   .24* .29* .22* 
 
    
 
   
 

























Happy p = .17 p = .46 p = .28  p = .47 p = .07 p =.28 
Angry p = .02*  p = .01* p <.001**  p = .48 p = .27 p = .43 
Sad p = .35 p = .36 p = .18  p = .23 p = .22 p = .43 
         
 











 Intensity Accuracy Immediate 
Group  .951 .771 .887 
Emotion    .002*   .045*    < .001** 
Gender  .142 .552 .246 
Group x 
Emotion 
 .830 .151 .421 
Group x 
Gender 
 .191 .274 .060 
Emotion x 
Gender 




 .153 .724 .447 
     








Rater Gender by Poser Gender by Time by Emotion (2 x 2 x 2 x 4) ANOVA, Significance of Effects 
 
 EF EV EI SE FM 
Poser Gender    < .001**    < .001**    < .001**  .014*   < .001** 
Rater Gender    .018*    .000**    .004**    .000** .075 
Time (2) .801 .696 .869 .912 .479 
Emotion (4)   < .001**   < .001**  < .001**   < .001**    < .001** 
PG x RG .349 .665 .117    .002** .238 
PG x T .679 .548 .400 .978 .438 
PG x E   .005*   .038*    .025*    .005*   .011* 
RG x T .362 .556 .144 .247 .966 
RG x E .085 .305 .162   <  .001**   .026* 
T x E .960 .463 .949 .797 .201 
PG x RG x T .767 .398 .056 .791 .835 
PG x RG x E .655   .027* .538 .374 .307 
PG x T x E .366 .480 .123 .811 .118 
RG x T x E .057 .526 .379 .484 .957 
PG x RG x T x E .012* .661 .325 .092 .001** 
      
 






Aim 1: Main Effects of Group: Pairwise Comparisons 
 






























































































Aim 1: Main Effects of Emotion: Pairwise Comparisons  
 
 




Aim 2: Main Effects of Emotion: Pairwise Comparisons 
 






























































































































Interaction: Poser Gender x Rater Gender 
 












Male Poser Female Poser Male Poser Female Poser































Happy Sad Angry Neutral
5a. Emotional Frequency (Time 1)



















Happy Sad Angry Neutral
5b. Emotional Frequency (Time 2)

































Happy Sad Angry Neutral
6a. Facial Mobility (Time 1)



















Happy Sad Angry Neutral
6b. Facial Mobility (Time 2)
















































































































































































































Main Effects of Poser Gender: Pairwise Comparisons 
 





Main Effect of Emotion 
 
































Emotional Variability Emotional Frequency Emotional Intensity Social Engagement Facial Mobility
Emotion





Main Effects of Rater Gender: Pairwise Comparisons 
 

































Group Comparison of BDI scores 
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